AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|.|200037056|Female|All other|2010-2014|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|30|200037056|Female|All other|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|45|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40634383|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Anaplastic astrocytoma|2010-2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|194|200037056|Female|Anaplastic astrocytoma|2010-2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40110236|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40311850|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|50|40222979|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40176480|Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Anaplastic oligodendroglioma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|.|200037056|Female|Anaplastic oligodendroglioma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|40634383|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Astrocytoma, NOS|2010-2014|~|~|~
0-19|0.2|0.2|0.2|Malignant|448|200037056|Female|Astrocytoma, NOS|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40110236|Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|82|40311850|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|40222979|Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|40176480|Female|Astrocytoma, NOS|2014|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39865121|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40634383|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634383|Female|Choroid plexus|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|124|200037056|Female|Choroid plexus|2010-2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|50|200037056|Female|Choroid plexus|2010-2014|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|26|40110236|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40110236|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40311850|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40311850|Female|Choroid plexus|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40222979|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40222979|Female|Choroid plexus|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40176480|Female|Choroid plexus|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40176480|Female|Choroid plexus|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|82|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|77|39998876|Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|76|40165421|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40634383|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634383|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|419|200037056|Female|Craniopharyngioma|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|200037056|Female|Craniopharyngioma|2010-2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|40110236|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40110236|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40311850|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40311850|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|40222979|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40222979|Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|40176480|Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40176480|Female|Craniopharyngioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|40634383|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Diffuse astrocytoma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|49|200037056|Female|Diffuse astrocytoma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|217|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|202|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.6|Malignant|222|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|232|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|174|40634383|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Embryonal/primitive/medulloblastoma|2010-2014|~|~|~
0-19|0.4|0.5|0.5|Malignant|932|200037056|Female|Embryonal/primitive/medulloblastoma|2010-2014|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|193|40110236|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.5|Malignant|181|40311850|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|40222979|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.4|0.6|0.5|Malignant|206|40176480|Female|Embryonal/primitive/medulloblastoma|2014|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|74|200037056|Female|Ependymoma variants|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200037056|Female|Ependymoma variants|2010-2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40110236|Female|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40110236|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40311850|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40311850|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40222979|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40222979|Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|40634383|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Ependymoma/anaplastic ependymoma|2010-2014|~|~|~
0-19|0.2|0.2|0.2|Malignant|445|200037056|Female|Ependymoma/anaplastic ependymoma|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40110236|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40311850|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|40222979|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40176480|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|40634383|Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|52|40634383|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|93|200037056|Female|Germ Cell Tumors|2010-2014|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|188|200037056|Female|Germ Cell Tumors|2010-2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|.|40110236|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|38|40110236|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Germ Cell Tumors|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|40311850|Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|19|40222979|Female|Germ Cell Tumors|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|47|40222979|Female|Germ Cell Tumors|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|40176480|Female|Germ Cell Tumors|2014|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|34|40176480|Female|Germ Cell Tumors|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40634383|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Glioblastoma|2010-2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|325|200037056|Female|Glioblastoma|2010-2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40110236|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|40311850|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|40222979|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|65|40176480|Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|232|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|232|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|246|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.7|Malignant|261|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|274|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|296|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.6|Malignant|254|40634383|Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|69|200037056|Female|Glioma malignant, NOS|2010-2014|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|1299|200037056|Female|Glioma malignant, NOS|2010-2014|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|.|40110236|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.9|0.8|Malignant|304|40110236|Female|Glioma malignant, NOS|2011|0.7|0.8|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|.|40311850|Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.5|Malignant|219|40311850|Female|Glioma malignant, NOS|2012|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.6|0.8|0.7|Malignant|276|40222979|Female|Glioma malignant, NOS|2013|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Glioma malignant, NOS|2014|~|~|~
0-19|0.6|0.7|0.6|Malignant|251|40176480|Female|Glioma malignant, NOS|2014|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|.|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|83|200037056|Female|Hemangioblastoma|2010-2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|200037056|Female|Hemangioblastoma|2010-2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40222979|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40222979|Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40176480|Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40176480|Female|Hemangioblastoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40382360|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|40576293|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|40634383|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40634383|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|276|200037056|Female|Hemangioma|2010-2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|200037056|Female|Hemangioma|2010-2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40110236|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40110236|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40311850|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40311850|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|40222979|Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40222979|Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40176480|Female|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40176480|Female|Hemangioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Local Extensions from Regional Tumors|2010-2014|~|~|~
0-19|~|~|~|Malignant|~|200037056|Female|Local Extensions from Regional Tumors|2010-2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|200037056|Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|40634383|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40634383|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|317|200037056|Female|Meningioma|2010-2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|200037056|Female|Meningioma|2010-2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40110236|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40110236|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|40311850|Female|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40311850|Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|40222979|Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40222979|Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40176480|Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40176480|Female|Meningioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|.|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|40576293|Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40634383|Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Mixed glioma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|62|200037056|Female|Mixed glioma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Mixed glioma|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|54|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|76|40576293|Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|87|40634383|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634383|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|357|200037056|Female|Neoplasm, unspecified|2010-2014|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|97|200037056|Female|Neoplasm, unspecified|2010-2014|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|68|40110236|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|20|40110236|Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|67|40311850|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|40311850|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|68|40222979|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|40222979|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|69|40176480|Female|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40176480|Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|113|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|39998876|Female|Nerve sheath, benign and malignant|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|151|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|122|40382360|Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|125|40634383|Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40634383|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|582|200037056|Female|Nerve sheath, benign and malignant|2010-2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200037056|Female|Nerve sheath, benign and malignant|2010-2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|123|40110236|Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40110236|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|125|40311850|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40311850|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|40222979|Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40222979|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|40176480|Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40176480|Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Neuroepithelial|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|31|200037056|Female|Neuroepithelial|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Neuroepithelial|2014|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|136|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|121|40165421|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|132|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|144|40634383|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|.|40634383|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|734|200037056|Female|Neuronal/glial, neuronal|2010-2014|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|92|200037056|Female|Neuronal/glial, neuronal|2010-2014|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|146|40110236|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40110236|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|149|40311850|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|16|40311850|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|156|40222979|Female|Neuronal/glial, neuronal|2013|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|21|40222979|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|144|40176480|Female|Neuronal/glial, neuronal|2014|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|23|40176480|Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40634383|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Oligodendroglioma|2010-2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|98|200037056|Female|Oligodendroglioma|2010-2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40110236|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40311850|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40176480|Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|.|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40634383|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634383|Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|176|200037056|Female|Other mesenchymal|2010-2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|27|200037056|Female|Other mesenchymal|2010-2014|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|26|40110236|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40110236|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40311850|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40311850|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|40222979|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40222979|Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|40176480|Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40176480|Female|Other mesenchymal|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|330|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|320|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|313|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|332|40382360|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|332|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|347|40670476|Female|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.1|1.0|Malignant|387|40634383|Female|Pilocytic astrocytoma|2010|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|200037056|Female|Pilocytic astrocytoma|2010-2014|~|~|~
0-19|0.9|1.0|0.9|Malignant|1831|200037056|Female|Pilocytic astrocytoma|2010-2014|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|352|40110236|Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.8|1.0|0.9|Malignant|364|40311850|Female|Pilocytic astrocytoma|2012|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|354|40222979|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.0|0.9|Malignant|380|40176480|Female|Pilocytic astrocytoma|2014|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634383|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40634383|Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|.|200037056|Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|69|200037056|Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40110236|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40110236|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40311850|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|40311850|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40222979|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|40222979|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40176480|Female|Pineal parenchymal|2014|~|~|~
0-19|~|~|~|Malignant|~|40176480|Female|Pineal parenchymal|2014|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|256|39865121|Female|Pituitary|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|299|39998876|Female|Pituitary|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|333|40165421|Female|Pituitary|2006|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|315|40382360|Female|Pituitary|2007|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|375|40576293|Female|Pituitary|2008|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|366|40670476|Female|Pituitary|2009|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|428|40634383|Female|Pituitary|2010|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40634383|Female|Pituitary|2010|~|~|~
0-19|1.0|1.1|1.0|Benign/Borderline|2074|200037056|Female|Pituitary|2010-2014|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|200037056|Female|Pituitary|2010-2014|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|417|40110236|Female|Pituitary|2011|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40110236|Female|Pituitary|2011|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|439|40311850|Female|Pituitary|2012|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40311850|Female|Pituitary|2012|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|407|40222979|Female|Pituitary|2013|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40222979|Female|Pituitary|2013|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|392|40176480|Female|Pituitary|2014|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40176480|Female|Pituitary|2014|~|~|~
0-19|1.8|2.1|1.9|Benign/Borderline|767|39865121|Female|Total|2004|1.8|2.1|1.9
0-19|3.1|3.5|3.3|Malignant|1308|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.1|2.4|2.3|Benign/Borderline|927|39998876|Female|Total|2005|2.2|2.5|2.3
0-19|2.9|3.3|3.1|Malignant|1230|39998876|Female|Total|2005|2.9|3.3|3.1
0-19|2.1|2.4|2.3|Benign/Borderline|935|40165421|Female|Total|2006|2.2|2.5|2.3
0-19|2.9|3.2|3.1|Malignant|1222|40165421|Female|Total|2006|2.9|3.2|3.0
0-19|2.1|2.4|2.3|Benign/Borderline|940|40382360|Female|Total|2007|2.2|2.5|2.3
0-19|3.0|3.4|3.2|Malignant|1290|40382360|Female|Total|2007|3.0|3.4|3.2
0-19|2.3|2.6|2.5|Benign/Borderline|1018|40576293|Female|Total|2008|2.4|2.7|2.5
0-19|3.0|3.3|3.2|Malignant|1279|40576293|Female|Total|2008|3.0|3.3|3.2
0-19|2.4|2.7|2.5|Benign/Borderline|1042|40670476|Female|Total|2009|2.4|2.7|2.6
0-19|3.0|3.4|3.2|Malignant|1286|40670476|Female|Total|2009|3.0|3.3|3.2
0-19|2.5|2.9|2.7|Benign/Borderline|1113|40634383|Female|Total|2010|2.6|2.9|2.7
0-19|3.0|3.4|3.2|Malignant|1286|40634383|Female|Total|2010|3.0|3.3|3.2
0-19|2.7|2.8|2.7|Benign/Borderline|5541|200037056|Female|Total|2010-2014|2.7|2.8|2.8
0-19|3.1|3.3|3.2|Malignant|6404|200037056|Female|Total|2010-2014|3.1|3.3|3.2
0-19|2.6|2.9|2.7|Benign/Borderline|1112|40110236|Female|Total|2011|2.6|2.9|2.8
0-19|3.1|3.5|3.3|Malignant|1329|40110236|Female|Total|2011|3.1|3.5|3.3
0-19|2.7|3.0|2.8|Benign/Borderline|1155|40311850|Female|Total|2012|2.7|3.0|2.9
0-19|2.8|3.2|3.0|Malignant|1212|40311850|Female|Total|2012|2.8|3.2|3.0
0-19|2.6|3.0|2.8|Benign/Borderline|1135|40222979|Female|Total|2013|2.7|3.0|2.8
0-19|3.1|3.4|3.3|Malignant|1306|40222979|Female|Total|2013|3.1|3.4|3.2
0-19|2.4|2.8|2.6|Benign/Borderline|1051|40176480|Female|Total|2014|2.5|2.8|2.6
0-19|3.1|3.4|3.3|Malignant|1310|40176480|Female|Total|2014|3.1|3.4|3.3
0-19|0.2|0.3|0.3|Benign/Borderline|113|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|151|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|122|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|125|40634383|Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40634383|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|582|200037056|Female|Tumors of Cranial and Spinal Nerves|2010-2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200037056|Female|Tumors of Cranial and Spinal Nerves|2010-2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|123|40110236|Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40110236|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|125|40311850|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40311850|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|40222979|Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40222979|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|40176480|Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40176480|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|188|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.9|3.2|3.0|Malignant|1210|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|194|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1139|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.8
0-19|0.4|0.6|0.5|Benign/Borderline|199|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1152|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.0|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|227|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.2|3.1|Malignant|1227|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|223|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|1226|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|207|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.6|0.5
0-19|2.8|3.1|3.0|Malignant|1204|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|228|40634383|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|2.8|3.2|3.0|Malignant|1207|40634383|Female|Tumors of Neuroepthelial Tissue|2010|2.8|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|1162|200037056|Female|Tumors of Neuroepthelial Tissue|2010-2014|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|6024|200037056|Female|Tumors of Neuroepthelial Tissue|2010-2014|2.9|3.1|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|232|40110236|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1249|40110236|Female|Tumors of Neuroepthelial Tissue|2011|2.9|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|243|40311850|Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.7|0.6
0-19|2.7|3.0|2.8|Malignant|1147|40311850|Female|Tumors of Neuroepthelial Tissue|2012|2.7|3.0|2.8
0-19|0.5|0.7|0.6|Benign/Borderline|247|40222979|Female|Tumors of Neuroepthelial Tissue|2013|0.5|0.7|0.6
0-19|2.9|3.2|3.0|Malignant|1217|40222979|Female|Tumors of Neuroepthelial Tissue|2013|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|220|40176480|Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.5
0-19|2.9|3.3|3.1|Malignant|1236|40176480|Female|Tumors of Neuroepthelial Tissue|2014|2.9|3.3|3.1
0-19|0.8|0.9|0.8|Benign/Borderline|338|39865121|Female|Tumors of Sellar Region|2004|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|376|39998876|Female|Tumors of Sellar Region|2005|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|409|40165421|Female|Tumors of Sellar Region|2006|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|410|40382360|Female|Tumors of Sellar Region|2007|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.1|1.0|Benign/Borderline|438|40576293|Female|Tumors of Sellar Region|2008|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|457|40670476|Female|Tumors of Sellar Region|2009|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.1|1.4|1.2|Benign/Borderline|519|40634383|Female|Tumors of Sellar Region|2010|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40634383|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.2|1.3|1.2|Benign/Borderline|2493|200037056|Female|Tumors of Sellar Region|2010-2014|1.2|1.3|1.2
0-19|~|~|~|Malignant|~|200037056|Female|Tumors of Sellar Region|2010-2014|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|501|40110236|Female|Tumors of Sellar Region|2011|1.1|1.4|1.2
0-19|~|~|~|Malignant|~|40110236|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|517|40311850|Female|Tumors of Sellar Region|2012|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40311850|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|491|40222979|Female|Tumors of Sellar Region|2013|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40222979|Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|475|40176480|Female|Tumors of Sellar Region|2014|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40176480|Female|Tumors of Sellar Region|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|99|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|40634383|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634383|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|576|200037056|Female|Tumors of the Meninges|2010-2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|43|200037056|Female|Tumors of the Meninges|2010-2014|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|104|40110236|Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40110236|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|125|40311850|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40311850|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|125|40222979|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40222979|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40176480|Female|Tumors of the Meninges|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40176480|Female|Tumors of the Meninges|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|39865121|Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|77|39998876|Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|20|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|85|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|77|40382360|Female|Unclassified Tumors|2007|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|114|40576293|Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|127|40634383|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40634383|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|634|200037056|Female|Unclassified Tumors|2010-2014|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|100|200037056|Female|Unclassified Tumors|2010-2014|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|131|40110236|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|20|40110236|Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|131|40311850|Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|40311850|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|125|40222979|Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40222979|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|122|40176480|Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40176480|Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|.|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|22|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|.|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|34|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|26|40634383|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634383|Female|Unique astrocytoma variants|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|126|200037056|Female|Unique astrocytoma variants|2010-2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|80|200037056|Female|Unique astrocytoma variants|2010-2014|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|16|40110236|Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|22|40110236|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|29|40311850|Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40311850|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|27|40222979|Female|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40222979|Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|29|40176480|Female|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40176480|Female|Unique astrocytoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|209288659|Male|All other|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|42|209288659|Male|All other|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42004894|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42004894|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42188304|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|42188304|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42054058|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|35|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|54|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42551068|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Anaplastic astrocytoma|2010-2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|218|209288659|Male|Anaplastic astrocytoma|2010-2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42004894|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42188304|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42054058|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.2|0.1|Malignant|55|41979659|Male|Anaplastic astrocytoma|2014|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Anaplastic oligodendroglioma|2010-2014|~|~|~
0-19|~|~|~|Malignant|~|209288659|Male|Anaplastic oligodendroglioma|2010-2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42004894|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42188304|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42551068|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Astrocytoma, NOS|2010-2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|491|209288659|Male|Astrocytoma, NOS|2010-2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|42004894|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|42188304|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|85|42054058|Male|Astrocytoma, NOS|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41979659|Male|Astrocytoma, NOS|2014|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42551068|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|.|42551068|Male|Choroid plexus|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|176|209288659|Male|Choroid plexus|2010-2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|51|209288659|Male|Choroid plexus|2010-2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42004894|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42004894|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42188304|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42188304|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42054058|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42054058|Male|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41979659|Male|Choroid plexus|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41979659|Male|Choroid plexus|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41889233|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42158997|Male|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|42367071|Male|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42609915|Male|Craniopharyngioma|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|82|42551068|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42551068|Male|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|416|209288659|Male|Craniopharyngioma|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|209288659|Male|Craniopharyngioma|2010-2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|42004894|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42004894|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|79|42188304|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42188304|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|42054058|Male|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42054058|Male|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|98|41979659|Male|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41979659|Male|Craniopharyngioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Diffuse astrocytoma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|70|209288659|Male|Diffuse astrocytoma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|.|42004894|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|42188304|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|293|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|276|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|293|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.8|Malignant|320|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|311|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|313|42551068|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Embryonal/primitive/medulloblastoma|2010-2014|~|~|~
0-19|0.7|0.7|0.7|Malignant|1431|209288659|Male|Embryonal/primitive/medulloblastoma|2010-2014|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|297|42004894|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|285|42188304|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.6|Malignant|270|42054058|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.7|0.7|Malignant|272|41979659|Male|Embryonal/primitive/medulloblastoma|2014|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|.|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|.|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|.|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|.|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|.|42551068|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42551068|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|92|209288659|Male|Ependymoma variants|2010-2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|209288659|Male|Ependymoma variants|2010-2014|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42004894|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42004894|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42188304|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42188304|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42054058|Male|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42054058|Male|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|105|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|113|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42551068|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Ependymoma/anaplastic ependymoma|2010-2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|561|209288659|Male|Ependymoma/anaplastic ependymoma|2010-2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|116|42004894|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|113|42188304|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|42054058|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|41979659|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|.|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|.|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|.|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|99|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|27|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|97|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42551068|Male|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|112|42551068|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|106|209288659|Male|Germ Cell Tumors|2010-2014|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|528|209288659|Male|Germ Cell Tumors|2010-2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42004894|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|.|42188304|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42188304|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|42054058|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|108|42054058|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|24|41979659|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|100|41979659|Male|Germ Cell Tumors|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42551068|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Glioblastoma|2010-2014|~|~|~
0-19|0.2|0.2|0.2|Malignant|393|209288659|Male|Glioblastoma|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|42004894|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|79|42188304|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|42054058|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|41979659|Male|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|222|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|239|42158997|Male|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|242|42367071|Male|Glioma malignant, NOS|2007|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|268|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|270|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.7|Malignant|280|42551068|Male|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|70|209288659|Male|Glioma malignant, NOS|2010-2014|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|1317|209288659|Male|Glioma malignant, NOS|2010-2014|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.6|0.7|0.6|Malignant|267|42004894|Male|Glioma malignant, NOS|2011|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Glioma malignant, NOS|2012|~|~|~
0-19|0.6|0.7|0.7|Malignant|274|42188304|Male|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|.|42054058|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|262|42054058|Male|Glioma malignant, NOS|2013|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|.|41979659|Male|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|236|41979659|Male|Glioma malignant, NOS|2014|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|.|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|.|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|92|209288659|Male|Hemangioblastoma|2010-2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|209288659|Male|Hemangioblastoma|2010-2014|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|.|42004894|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42004894|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|.|42188304|Male|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42188304|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42054058|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42054058|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41979659|Male|Hemangioblastoma|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41979659|Male|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|.|41889233|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42158997|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42551068|Male|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42551068|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|277|209288659|Male|Hemangioma|2010-2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|209288659|Male|Hemangioma|2010-2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|63|42004894|Male|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42004894|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|42188304|Male|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42188304|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42054058|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42054058|Male|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|41979659|Male|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41979659|Male|Hemangioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Local Extensions from Regional Tumors|2010-2014|~|~|~
0-19|~|~|~|Malignant|~|209288659|Male|Local Extensions from Regional Tumors|2010-2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42004894|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|42188304|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Lymphomas and Hematopoietic Neoplasms|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|39|209288659|Male|Lymphomas and Hematopoietic Neoplasms|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42004894|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|42188304|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|49|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42551068|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42551068|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|285|209288659|Male|Meningioma|2010-2014|0.1|0.2|0.1
0-19|0.0|0.0|0.0|Malignant|.|209288659|Male|Meningioma|2010-2014|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|64|42004894|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42004894|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|42188304|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42188304|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42054058|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42054058|Male|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|41979659|Male|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41979659|Male|Meningioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42551068|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Mixed glioma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|62|209288659|Male|Mixed glioma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42004894|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Mixed glioma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|42188304|Male|Mixed glioma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|Mixed glioma|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|55|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|25|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|62|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|47|42541971|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|.|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|87|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|80|42551068|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|.|42551068|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|339|209288659|Male|Neoplasm, unspecified|2010-2014|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|103|209288659|Male|Neoplasm, unspecified|2010-2014|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|68|42004894|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|42004894|Male|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|60|42188304|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|28|42188304|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|66|42054058|Male|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42054058|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|67|41979659|Male|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|41979659|Male|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|124|41889233|Male|Nerve sheath, benign and malignant|2004|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|167|42158997|Male|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|147|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|42551068|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551068|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|667|209288659|Male|Nerve sheath, benign and malignant|2010-2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|209288659|Male|Nerve sheath, benign and malignant|2010-2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|42004894|Male|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42004894|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|145|42188304|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42188304|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|134|42054058|Male|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42054058|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|125|41979659|Male|Nerve sheath, benign and malignant|2014|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41979659|Male|Nerve sheath, benign and malignant|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Neuroepithelial|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|209288659|Male|Neuroepithelial|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42004894|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|42188304|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|41979659|Male|Neuroepithelial|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|157|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|172|42367071|Male|Neuronal/glial, neuronal|2007|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|175|42541971|Male|Neuronal/glial, neuronal|2008|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|29|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|172|42551068|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42551068|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|904|209288659|Male|Neuronal/glial, neuronal|2010-2014|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|98|209288659|Male|Neuronal/glial, neuronal|2010-2014|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|183|42004894|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|.|42004894|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|202|42188304|Male|Neuronal/glial, neuronal|2012|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|18|42188304|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|183|42054058|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|21|42054058|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|165|41979659|Male|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|26|41979659|Male|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42541971|Male|Oligodendroglioma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42551068|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Oligodendroglioma|2010-2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|100|209288659|Male|Oligodendroglioma|2010-2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42004894|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42188304|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|42054058|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41979659|Male|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|42551068|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42551068|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|163|209288659|Male|Other mesenchymal|2010-2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|37|209288659|Male|Other mesenchymal|2010-2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42004894|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42004894|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|42188304|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42188304|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42054058|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42054058|Male|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41979659|Male|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41979659|Male|Other mesenchymal|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|369|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|347|42006384|Male|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.9|Malignant|357|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|347|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|387|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|360|42609915|Male|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|372|42551068|Male|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Pilocytic astrocytoma|2010-2014|~|~|~
0-19|0.9|1.0|0.9|Malignant|1929|209288659|Male|Pilocytic astrocytoma|2010-2014|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|383|42004894|Male|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|412|42188304|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|417|42054058|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|0.9|0.8|Malignant|354|41979659|Male|Pilocytic astrocytoma|2014|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551068|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42551068|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|209288659|Male|Pineal parenchymal|2010-2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|89|209288659|Male|Pineal parenchymal|2010-2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42004894|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|42004894|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42188304|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|.|42188304|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42054058|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|42054058|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41979659|Male|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|.|41979659|Male|Pineal parenchymal|2014|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|85|41889233|Male|Pituitary|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|118|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|127|42541971|Male|Pituitary|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|153|42609915|Male|Pituitary|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|134|42551068|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551068|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|751|209288659|Male|Pituitary|2010-2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|209288659|Male|Pituitary|2010-2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|144|42004894|Male|Pituitary|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42004894|Male|Pituitary|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|163|42188304|Male|Pituitary|2012|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42188304|Male|Pituitary|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42054058|Male|Pituitary|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42054058|Male|Pituitary|2013|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|166|41979659|Male|Pituitary|2014|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41979659|Male|Pituitary|2014|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|673|41889233|Male|Total|2004|1.5|1.7|1.6
0-19|3.4|3.8|3.6|Malignant|1500|41889233|Male|Total|2004|3.4|3.8|3.6
0-19|1.7|2.0|1.8|Benign/Borderline|769|42006384|Male|Total|2005|1.7|2.0|1.8
0-19|3.2|3.6|3.4|Malignant|1420|42006384|Male|Total|2005|3.2|3.6|3.4
0-19|1.7|2.0|1.9|Benign/Borderline|792|42158997|Male|Total|2006|1.8|2.0|1.9
0-19|3.4|3.8|3.6|Malignant|1498|42158997|Male|Total|2006|3.4|3.7|3.6
0-19|1.8|2.1|1.9|Benign/Borderline|827|42367071|Male|Total|2007|1.8|2.1|2.0
0-19|3.4|3.8|3.6|Malignant|1514|42367071|Male|Total|2007|3.4|3.8|3.6
0-19|1.8|2.1|1.9|Benign/Borderline|829|42541971|Male|Total|2008|1.8|2.1|1.9
0-19|3.6|3.9|3.8|Malignant|1591|42541971|Male|Total|2008|3.6|3.9|3.7
0-19|2.0|2.3|2.1|Benign/Borderline|915|42609915|Male|Total|2009|2.0|2.3|2.1
0-19|3.5|3.8|3.6|Malignant|1544|42609915|Male|Total|2009|3.4|3.8|3.6
0-19|1.9|2.2|2.0|Benign/Borderline|868|42551068|Male|Total|2010|1.9|2.2|2.0
0-19|3.6|3.9|3.8|Malignant|1592|42551068|Male|Total|2010|3.6|3.9|3.7
0-19|2.1|2.2|2.2|Benign/Borderline|4518|209288659|Male|Total|2010-2014|2.1|2.2|2.2
0-19|3.6|3.8|3.7|Malignant|7716|209288659|Male|Total|2010-2014|3.6|3.8|3.7
0-19|2.0|2.3|2.1|Benign/Borderline|902|42004894|Male|Total|2011|2.0|2.3|2.1
0-19|3.5|3.9|3.7|Malignant|1551|42004894|Male|Total|2011|3.5|3.9|3.7
0-19|2.1|2.4|2.3|Benign/Borderline|954|42188304|Male|Total|2012|2.1|2.4|2.3
0-19|3.6|4.0|3.8|Malignant|1591|42188304|Male|Total|2012|3.6|4.0|3.8
0-19|2.0|2.3|2.1|Benign/Borderline|906|42054058|Male|Total|2013|2.0|2.3|2.2
0-19|3.5|3.9|3.7|Malignant|1546|42054058|Male|Total|2013|3.5|3.9|3.7
0-19|2.0|2.3|2.1|Benign/Borderline|903|41979659|Male|Total|2014|2.0|2.3|2.2
0-19|3.3|3.7|3.5|Malignant|1470|41979659|Male|Total|2014|3.3|3.7|3.5
0-19|0.2|0.4|0.3|Benign/Borderline|124|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|167|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|147|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|42551068|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551068|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|670|209288659|Male|Tumors of Cranial and Spinal Nerves|2010-2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|209288659|Male|Tumors of Cranial and Spinal Nerves|2010-2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|42004894|Male|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42004894|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|145|42188304|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42188304|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42054058|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42054058|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|41979659|Male|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41979659|Male|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|229|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.1|3.4|3.3|Malignant|1358|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|258|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1286|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.2|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|259|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1349|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|263|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1366|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.1|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|275|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.2|3.6|3.4|Malignant|1428|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.5|3.4
0-19|0.6|0.7|0.6|Benign/Borderline|267|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1401|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.5|3.3
0-19|0.6|0.7|0.6|Benign/Borderline|275|42551068|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.2|3.6|3.4|Malignant|1437|42551068|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.6|3.4
0-19|0.6|0.7|0.7|Benign/Borderline|1418|209288659|Male|Tumors of Neuroepthelial Tissue|2010-2014|0.6|0.7|0.7
0-19|3.3|3.4|3.3|Malignant|6959|209288659|Male|Tumors of Neuroepthelial Tissue|2010-2014|3.2|3.4|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|290|42004894|Male|Tumors of Neuroepthelial Tissue|2011|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1416|42004894|Male|Tumors of Neuroepthelial Tissue|2011|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|306|42188304|Male|Tumors of Neuroepthelial Tissue|2012|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1424|42188304|Male|Tumors of Neuroepthelial Tissue|2012|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|287|42054058|Male|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.1|3.5|3.3|Malignant|1390|42054058|Male|Tumors of Neuroepthelial Tissue|2013|3.1|3.5|3.3
0-19|0.6|0.7|0.6|Benign/Borderline|262|41979659|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.6
0-19|3.0|3.3|3.2|Malignant|1322|41979659|Male|Tumors of Neuroepthelial Tissue|2014|3.0|3.3|3.1
0-19|0.3|0.5|0.4|Benign/Borderline|168|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|211|42006384|Male|Tumors of Sellar Region|2005|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|171|42158997|Male|Tumors of Sellar Region|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|202|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|219|42541971|Male|Tumors of Sellar Region|2008|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|233|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|216|42551068|Male|Tumors of Sellar Region|2010|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42551068|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|1167|209288659|Male|Tumors of Sellar Region|2010-2014|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|209288659|Male|Tumors of Sellar Region|2010-2014|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|213|42004894|Male|Tumors of Sellar Region|2011|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42004894|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|242|42188304|Male|Tumors of Sellar Region|2012|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42188304|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|237|42054058|Male|Tumors of Sellar Region|2013|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|42054058|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|264|41979659|Male|Tumors of Sellar Region|2014|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|41979659|Male|Tumors of Sellar Region|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|42006384|Male|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|42367071|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|87|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|42551068|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42551068|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|540|209288659|Male|Tumors of the Meninges|2010-2014|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|55|209288659|Male|Tumors of the Meninges|2010-2014|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|121|42004894|Male|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42004894|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|121|42188304|Male|Tumors of the Meninges|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42188304|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|102|42054058|Male|Tumors of the Meninges|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42054058|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|41979659|Male|Tumors of the Meninges|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41979659|Male|Tumors of the Meninges|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|74|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|84|42158997|Male|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|114|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|27|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|86|42541971|Male|Unclassified Tumors|2008|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|.|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|146|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|132|42551068|Male|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|.|42551068|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|617|209288659|Male|Unclassified Tumors|2010-2014|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|111|209288659|Male|Unclassified Tumors|2010-2014|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|131|42004894|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|42004894|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|118|42188304|Male|Unclassified Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|31|42188304|Male|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|120|42054058|Male|Unclassified Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|42054058|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|119|41979659|Male|Unclassified Tumors|2014|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|27|41979659|Male|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|28|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|39|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|.|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|39|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|26|42551068|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|.|42551068|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|159|209288659|Male|Unique astrocytoma variants|2010-2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|114|209288659|Male|Unique astrocytoma variants|2010-2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|35|42004894|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|42004894|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|34|42188304|Male|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|42188304|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|32|42054058|Male|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|42054058|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|32|41979659|Male|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|.|41979659|Male|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|83185451|Male and Female|All other|2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|31|409325715|Male and Female|All other|2010-2014|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|72|409325715|Male and Female|All other|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82115130|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|82500154|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|82277037|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|82156139|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|66|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|85|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|69|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|83185451|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Anaplastic astrocytoma|2010-2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|412|409325715|Male and Female|Anaplastic astrocytoma|2010-2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|82115130|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82500154|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|93|82277037|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|95|82156139|Male and Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83185451|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Anaplastic oligodendroglioma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|29|409325715|Male and Female|Anaplastic oligodendroglioma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82115130|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|82500154|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|82277037|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|82156139|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|179|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|216|83185451|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Astrocytoma, NOS|2010-2014|~|~|~
0-19|0.2|0.2|0.2|Malignant|939|409325715|Male and Female|Astrocytoma, NOS|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82115130|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|165|82500154|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82277037|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|82156139|Male and Female|Astrocytoma, NOS|2014|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|54|82005260|Male and Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|66|83185451|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83185451|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|300|409325715|Male and Female|Choroid plexus|2010-2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|101|409325715|Male and Female|Choroid plexus|2010-2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|82115130|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82115130|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82500154|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|82500154|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|62|82277037|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82277037|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|54|82156139|Male and Female|Choroid plexus|2014|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|82156139|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|165|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|170|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|180|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|155|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|171|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|173|83185451|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83185451|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|835|409325715|Male and Female|Craniopharyngioma|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|409325715|Male and Female|Craniopharyngioma|2010-2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|153|82115130|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82115130|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|82500154|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82500154|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|173|82277037|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82277037|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|181|82156139|Male and Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82156139|Male and Female|Craniopharyngioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|40|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|83185451|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Diffuse astrocytoma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|119|409325715|Male and Female|Diffuse astrocytoma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82115130|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82500154|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|82277037|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|82156139|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|510|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|462|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|495|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|520|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|552|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|514|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|487|83185451|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Embryonal/primitive/medulloblastoma|2010-2014|~|~|~
0-19|0.6|0.6|0.6|Malignant|2363|409325715|Male and Female|Embryonal/primitive/medulloblastoma|2010-2014|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|490|82115130|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82500154|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|456|82277037|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.6|Malignant|478|82156139|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83185451|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83185451|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|166|409325715|Male and Female|Ependymoma variants|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|409325715|Male and Female|Ependymoma variants|2010-2014|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|42|82115130|Male and Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82115130|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82500154|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82500154|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82277037|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82277037|Male and Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|82156139|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|199|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|216|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|207|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|212|83185451|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Ependymoma/anaplastic ependymoma|2010-2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|1006|409325715|Male and Female|Ependymoma/anaplastic ependymoma|2010-2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|212|82115130|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|82500154|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|82277037|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|82156139|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|144|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|46|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|140|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|40|83185451|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|164|83185451|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|199|409325715|Male and Female|Germ Cell Tumors|2010-2014|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|716|409325715|Male and Female|Germ Cell Tumors|2010-2014|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82115130|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|137|82115130|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82500154|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|130|82500154|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|82277037|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|155|82277037|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|82156139|Male and Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|134|82156139|Male and Female|Germ Cell Tumors|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|99|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|112|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83185451|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Glioblastoma|2010-2014|~|~|~
0-19|0.2|0.2|0.2|Malignant|718|409325715|Male and Female|Glioblastoma|2010-2014|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|154|82115130|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|153|82500154|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|159|82277037|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|140|82156139|Male and Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|454|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|485|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|503|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|542|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|566|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|19|83185451|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|534|83185451|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|139|409325715|Male and Female|Glioma malignant, NOS|2010-2014|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|2616|409325715|Male and Female|Glioma malignant, NOS|2010-2014|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|28|82115130|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
0-19|0.6|0.8|0.7|Malignant|571|82115130|Male and Female|Glioma malignant, NOS|2011|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|31|82500154|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.7|0.6|Malignant|493|82500154|Male and Female|Glioma malignant, NOS|2012|0.5|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|28|82277037|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|538|82277037|Male and Female|Glioma malignant, NOS|2013|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|33|82156139|Male and Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|487|82156139|Male and Female|Glioma malignant, NOS|2014|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|22|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|83185451|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83185451|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|175|409325715|Male and Female|Hemangioblastoma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|409325715|Male and Female|Hemangioblastoma|2010-2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82115130|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82115130|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82500154|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82500154|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|82277037|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82277037|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|46|82156139|Male and Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82156139|Male and Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|42|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|77|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|77|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|110|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|91|83185451|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83185451|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|553|409325715|Male and Female|Hemangioma|2010-2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|409325715|Male and Female|Hemangioma|2010-2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|126|82115130|Male and Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82115130|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|122|82500154|Male and Female|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82500154|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|110|82277037|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82277037|Male and Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|105|82156139|Male and Female|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82156139|Male and Female|Hemangioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83185451|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Local Extensions from Regional Tumors|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|409325715|Male and Female|Local Extensions from Regional Tumors|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82115130|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|82500154|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|82277037|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|82156139|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83185451|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|62|409325715|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82115130|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82500154|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|82277037|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|82156139|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|92|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|99|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|103|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|116|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|113|83185451|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83185451|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|602|409325715|Male and Female|Meningioma|2010-2014|0.1|0.2|0.1
0-19|0.0|0.0|0.0|Malignant|32|409325715|Male and Female|Meningioma|2010-2014|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|130|82115130|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82115130|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|82500154|Male and Female|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82500154|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|123|82277037|Male and Female|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82277037|Male and Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|123|82156139|Male and Female|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82156139|Male and Female|Meningioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|83185451|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Mixed glioma|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|124|409325715|Male and Female|Mixed glioma|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|82115130|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|82500154|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82277037|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Mixed glioma|2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82156139|Male and Female|Mixed glioma|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|109|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|37|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|101|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|114|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|39|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|123|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|148|83280391|Male and Female|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|167|83185451|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83185451|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|696|409325715|Male and Female|Neoplasm, unspecified|2010-2014|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|200|409325715|Male and Female|Neoplasm, unspecified|2010-2014|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|136|82115130|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|36|82115130|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|127|82500154|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|54|82500154|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|134|82277037|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|40|82277037|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|136|82156139|Male and Female|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|48|82156139|Male and Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|237|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|318|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|277|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|295|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|258|83185451|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83185451|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1249|409325715|Male and Female|Nerve sheath, benign and malignant|2010-2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|24|409325715|Male and Female|Nerve sheath, benign and malignant|2010-2014|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|255|82115130|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82115130|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|82500154|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82500154|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|261|82277037|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82277037|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|208|82156139|Male and Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82156139|Male and Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83185451|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Neuroepithelial|2010-2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|48|409325715|Male and Female|Neuroepithelial|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82115130|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|82500154|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|82277037|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|82156139|Male and Female|Neuroepithelial|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|263|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|295|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|278|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|309|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|61|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|307|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|57|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|292|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|316|83185451|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83185451|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|1638|409325715|Male and Female|Neuronal/glial, neuronal|2010-2014|0.4|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|190|409325715|Male and Female|Neuronal/glial, neuronal|2010-2014|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|329|82115130|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|33|82115130|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|351|82500154|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|34|82500154|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|339|82277037|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|42|82277037|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|309|82156139|Male and Female|Neuronal/glial, neuronal|2014|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|49|82156139|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|54|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|51|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|42|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|45|83185451|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Oligodendroglioma|2010-2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|198|409325715|Male and Female|Oligodendroglioma|2010-2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82115130|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|47|82500154|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82277037|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82156139|Male and Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|26|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82749431|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|47|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|49|83185451|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83185451|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|339|409325715|Male and Female|Other mesenchymal|2010-2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|64|409325715|Male and Female|Other mesenchymal|2010-2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|82115130|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82115130|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|92|82500154|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|82500154|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|70|82277037|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82277037|Male and Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|69|82156139|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82156139|Male and Female|Other mesenchymal|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|699|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|667|82005260|Male and Female|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|670|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|679|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.9|Malignant|719|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|707|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.0|0.9|Malignant|759|83185451|Male and Female|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|409325715|Male and Female|Pilocytic astrocytoma|2010-2014|~|~|~
0-19|0.9|1.0|0.9|Malignant|3760|409325715|Male and Female|Pilocytic astrocytoma|2010-2014|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|735|82115130|Male and Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|0.9|Malignant|776|82500154|Male and Female|Pilocytic astrocytoma|2012|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|0.9|Malignant|771|82277037|Male and Female|Pilocytic astrocytoma|2013|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|1.0|0.9|Malignant|734|82156139|Male and Female|Pilocytic astrocytoma|2014|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185451|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83185451|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|40|409325715|Male and Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|158|409325715|Male and Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82115130|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82115130|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82500154|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82500154|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82277037|Male and Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|82277037|Male and Female|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82156139|Male and Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|82156139|Male and Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|341|81754354|Male and Female|Pituitary|2004|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|417|82005260|Male and Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.5|0.5|0.5|Benign/Borderline|424|82324418|Male and Female|Pituitary|2006|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|432|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|502|83118264|Male and Female|Pituitary|2008|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|519|83280391|Male and Female|Pituitary|2009|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|562|83185451|Male and Female|Pituitary|2010|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83185451|Male and Female|Pituitary|2010|~|~|~
0-19|0.7|0.7|0.7|Benign/Borderline|2825|409325715|Male and Female|Pituitary|2010-2014|0.7|0.7|0.7
0-19|~|~|~|Malignant|~|409325715|Male and Female|Pituitary|2010-2014|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|561|82115130|Male and Female|Pituitary|2011|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82115130|Male and Female|Pituitary|2011|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|602|82500154|Male and Female|Pituitary|2012|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82500154|Male and Female|Pituitary|2012|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|555|82277037|Male and Female|Pituitary|2013|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82277037|Male and Female|Pituitary|2013|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|558|82156139|Male and Female|Pituitary|2014|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82156139|Male and Female|Pituitary|2014|~|~|~
0-19|1.7|1.8|1.8|Benign/Borderline|1440|81754354|Male and Female|Total|2004|1.7|1.9|1.8
0-19|3.3|3.6|3.4|Malignant|2808|81754354|Male and Female|Total|2004|3.3|3.6|3.4
0-19|1.9|2.1|2.0|Benign/Borderline|1696|82005260|Male and Female|Total|2005|2.0|2.2|2.1
0-19|3.1|3.4|3.2|Malignant|2650|82005260|Male and Female|Total|2005|3.1|3.4|3.2
0-19|2.0|2.2|2.1|Benign/Borderline|1727|82324418|Male and Female|Total|2006|2.0|2.2|2.1
0-19|3.2|3.4|3.3|Malignant|2720|82324418|Male and Female|Total|2006|3.2|3.4|3.3
0-19|2.0|2.2|2.1|Benign/Borderline|1767|82749431|Male and Female|Total|2007|2.0|2.2|2.1
0-19|3.3|3.5|3.4|Malignant|2804|82749431|Male and Female|Total|2007|3.3|3.5|3.4
0-19|2.1|2.3|2.2|Benign/Borderline|1847|83118264|Male and Female|Total|2008|2.1|2.3|2.2
0-19|3.3|3.6|3.5|Malignant|2870|83118264|Male and Female|Total|2008|3.3|3.6|3.5
0-19|2.2|2.4|2.3|Benign/Borderline|1957|83280391|Male and Female|Total|2009|2.2|2.5|2.3
0-19|3.3|3.5|3.4|Malignant|2830|83280391|Male and Female|Total|2009|3.3|3.5|3.4
0-19|2.3|2.5|2.4|Benign/Borderline|1981|83185451|Male and Female|Total|2010|2.3|2.5|2.4
0-19|3.3|3.6|3.5|Malignant|2878|83185451|Male and Female|Total|2010|3.3|3.6|3.5
0-19|2.4|2.5|2.4|Benign/Borderline|10059|409325715|Male and Female|Total|2010-2014|2.4|2.5|2.5
0-19|3.4|3.5|3.5|Malignant|14120|409325715|Male and Female|Total|2010-2014|3.4|3.5|3.4
0-19|2.3|2.5|2.4|Benign/Borderline|2014|82115130|Male and Female|Total|2011|2.3|2.6|2.5
0-19|3.4|3.6|3.5|Malignant|2880|82115130|Male and Female|Total|2011|3.4|3.6|3.5
0-19|2.4|2.7|2.5|Benign/Borderline|2109|82500154|Male and Female|Total|2012|2.4|2.7|2.6
0-19|3.3|3.5|3.4|Malignant|2803|82500154|Male and Female|Total|2012|3.3|3.5|3.4
0-19|2.4|2.6|2.5|Benign/Borderline|2041|82277037|Male and Female|Total|2013|2.4|2.6|2.5
0-19|3.3|3.6|3.5|Malignant|2852|82277037|Male and Female|Total|2013|3.3|3.6|3.5
0-19|2.3|2.5|2.4|Benign/Borderline|1954|82156139|Male and Female|Total|2014|2.3|2.5|2.4
0-19|3.3|3.5|3.4|Malignant|2780|82156139|Male and Female|Total|2014|3.3|3.5|3.4
0-19|0.3|0.3|0.3|Benign/Borderline|237|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|318|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|277|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|295|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|258|83185451|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83185451|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1252|409325715|Male and Female|Tumors of Cranial and Spinal Nerves|2010-2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|24|409325715|Male and Female|Tumors of Cranial and Spinal Nerves|2010-2014|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|255|82115130|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82115130|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|82500154|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82500154|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|262|82277037|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82277037|Male and Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|210|82156139|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82156139|Male and Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|417|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.2|Malignant|2568|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|452|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|2425|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.8|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|458|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|2.9|3.2|3.1|Malignant|2501|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.2|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|490|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|3.0|3.3|3.1|Malignant|2593|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|498|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2654|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.1|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|474|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.0|3.3|3.1|Malignant|2605|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|503|83185451|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2644|83185451|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.1|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|2580|409325715|Male and Female|Tumors of Neuroepthelial Tissue|2010-2014|0.6|0.7|0.6
0-19|3.1|3.2|3.2|Malignant|12983|409325715|Male and Female|Tumors of Neuroepthelial Tissue|2010-2014|3.1|3.2|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|522|82115130|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|2665|82115130|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.1|3.4|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|549|82500154|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.7
0-19|3.0|3.2|3.1|Malignant|2571|82500154|Male and Female|Tumors of Neuroepthelial Tissue|2012|3.0|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|534|82277037|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2607|82277037|Male and Female|Tumors of Neuroepthelial Tissue|2013|3.0|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|482|82156139|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2558|82156139|Male and Female|Tumors of Neuroepthelial Tissue|2014|3.0|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|506|81754354|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|587|82005260|Male and Female|Tumors of Sellar Region|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|580|82324418|Male and Female|Tumors of Sellar Region|2006|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|612|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|657|83118264|Male and Female|Tumors of Sellar Region|2008|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|690|83280391|Male and Female|Tumors of Sellar Region|2009|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|735|83185451|Male and Female|Tumors of Sellar Region|2010|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|83185451|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.9|0.9|0.9|Benign/Borderline|3660|409325715|Male and Female|Tumors of Sellar Region|2010-2014|0.9|0.9|0.9
0-19|~|~|~|Malignant|~|409325715|Male and Female|Tumors of Sellar Region|2010-2014|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|714|82115130|Male and Female|Tumors of Sellar Region|2011|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|82115130|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|759|82500154|Male and Female|Tumors of Sellar Region|2012|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|82500154|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|728|82277037|Male and Female|Tumors of Sellar Region|2013|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|82277037|Male and Female|Tumors of Sellar Region|2013|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|739|82156139|Male and Female|Tumors of Sellar Region|2014|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|82156139|Male and Female|Tumors of Sellar Region|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|147|81754354|Male and Female|Tumors of the Meninges|2004|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|194|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|167|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|175|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|194|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|186|83185451|Male and Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|83185451|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1116|409325715|Male and Female|Tumors of the Meninges|2010-2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|98|409325715|Male and Female|Tumors of the Meninges|2010-2014|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|225|82115130|Male and Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|16|82115130|Male and Female|Tumors of the Meninges|2011|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|246|82500154|Male and Female|Tumors of the Meninges|2012|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|21|82500154|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|227|82277037|Male and Female|Tumors of the Meninges|2013|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|23|82277037|Male and Female|Tumors of the Meninges|2013|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|238|82156139|Male and Female|Tumors of the Meninges|2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|18|82156139|Male and Female|Tumors of the Meninges|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|102|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|151|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|191|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|44|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|200|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|258|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|40|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|259|83185451|Male and Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|28|83185451|Male and Female|Unclassified Tumors|2010|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1251|409325715|Male and Female|Unclassified Tumors|2010-2014|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|211|409325715|Male and Female|Unclassified Tumors|2010-2014|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|262|82115130|Male and Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|37|82115130|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|249|82500154|Male and Female|Unclassified Tumors|2012|0.3|0.3|0.3
0-19|0.1|0.1|0.1|Malignant|57|82500154|Male and Female|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|245|82277037|Male and Female|Unclassified Tumors|2013|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|43|82277037|Male and Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|241|82156139|Male and Female|Unclassified Tumors|2014|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|51|82156139|Male and Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|50|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|57|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|29|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|49|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|57|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|63|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|72|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|52|83185451|Male and Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|26|83185451|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|285|409325715|Male and Female|Unique astrocytoma variants|2010-2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|194|409325715|Male and Female|Unique astrocytoma variants|2010-2014|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|51|82115130|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|47|82115130|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|63|82500154|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|82500154|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|59|82277037|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|41|82277037|Male and Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82156139|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82156139|Male and Female|Unique astrocytoma variants|2014|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|.|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|.|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|.|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|.|116624437|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|.|116624437|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|78|591050309|Female|All other|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|95|591050309|Female|All other|2010-2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116968997|Female|All other|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|116968997|Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|.|119269696|Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119269696|Female|All other|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|120497646|Female|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|23|120497646|Female|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121775584|Female|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|21|121775584|Female|All other|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|509|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|530|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|499|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|501|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116624437|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|564|116624437|Female|Anaplastic astrocytoma|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|591050309|Female|Anaplastic astrocytoma|2010-2014|~|~|~
20+|0.5|0.5|0.5|Malignant|2929|591050309|Female|Anaplastic astrocytoma|2010-2014|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|116968997|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|560|116968997|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|119269696|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|580|119269696|Female|Anaplastic astrocytoma|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|120497646|Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.5|0.5|0.5|Malignant|634|120497646|Female|Anaplastic astrocytoma|2013|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|121775584|Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.4|0.5|0.5|Malignant|612|121775584|Female|Anaplastic astrocytoma|2014|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|183|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|166|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|138|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|155|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|169|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|142|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116624437|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|131|116624437|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|591050309|Female|Anaplastic oligodendroglioma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|735|591050309|Female|Anaplastic oligodendroglioma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116968997|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|148|116968997|Female|Anaplastic oligodendroglioma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119269696|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|165|119269696|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|120497646|Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|144|120497646|Female|Anaplastic oligodendroglioma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121775584|Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|150|121775584|Female|Anaplastic oligodendroglioma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|569|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|558|110320645|Female|Astrocytoma, NOS|2005|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|534|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|533|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|490|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|481|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116624437|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|474|116624437|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|591050309|Female|Astrocytoma, NOS|2010-2014|~|~|~
20+|0.4|0.4|0.4|Malignant|2308|591050309|Female|Astrocytoma, NOS|2010-2014|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116968997|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|453|116968997|Female|Astrocytoma, NOS|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119269696|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.4|0.4|Malignant|481|119269696|Female|Astrocytoma, NOS|2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|120497646|Female|Astrocytoma, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|435|120497646|Female|Astrocytoma, NOS|2013|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|121775584|Female|Astrocytoma, NOS|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|476|121775584|Female|Astrocytoma, NOS|2014|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|38|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|42|111567226|Female|Choroid plexus|2006|0.0|0.1|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|55|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|44|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|116624437|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116624437|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|224|591050309|Female|Choroid plexus|2010-2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|591050309|Female|Choroid plexus|2010-2014|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|116968997|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116968997|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|119269696|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119269696|Female|Choroid plexus|2012|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|120497646|Female|Choroid plexus|2013|0.0|0.1|0.0
20+|~|~|~|Malignant|~|120497646|Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|43|121775584|Female|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|121775584|Female|Choroid plexus|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|201|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|183|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|199|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|221|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|236|116624437|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116624437|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1107|591050309|Female|Craniopharyngioma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|591050309|Female|Craniopharyngioma|2010-2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|116968997|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116968997|Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|218|119269696|Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119269696|Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|120497646|Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120497646|Female|Craniopharyngioma|2013|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|207|121775584|Female|Craniopharyngioma|2014|0.1|0.2|0.2
20+|~|~|~|Malignant|~|121775584|Female|Craniopharyngioma|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|93|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|132|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|133|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116624437|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|116624437|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|591050309|Female|Diffuse astrocytoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|496|591050309|Female|Diffuse astrocytoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116968997|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|111|116968997|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119269696|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|94|119269696|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120497646|Female|Diffuse astrocytoma|2013|~|~|~
20+|0.0|0.1|0.1|Malignant|71|120497646|Female|Diffuse astrocytoma|2013|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121775584|Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.0|Malignant|60|121775584|Female|Diffuse astrocytoma|2014|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|85|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|91|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|89|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|104|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116624437|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|73|116624437|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|591050309|Female|Embryonal/primitive/medulloblastoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|382|591050309|Female|Embryonal/primitive/medulloblastoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116968997|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|69|116968997|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119269696|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|81|119269696|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120497646|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|88|120497646|Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121775584|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|71|121775584|Female|Embryonal/primitive/medulloblastoma|2014|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|148|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|112|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|116624437|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116624437|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|609|591050309|Female|Ependymoma variants|2010-2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|591050309|Female|Ependymoma variants|2010-2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|117|116968997|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116968997|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|128|119269696|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|119269696|Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|120497646|Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|120497646|Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|125|121775584|Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|121775584|Female|Ependymoma variants|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|291|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|301|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|293|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|295|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|312|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|342|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116624437|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|294|116624437|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|31|591050309|Female|Ependymoma/anaplastic ependymoma|2010-2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|1388|591050309|Female|Ependymoma/anaplastic ependymoma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|116968997|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|297|116968997|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119269696|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|302|119269696|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120497646|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|269|120497646|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|121775584|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|236|121775584|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|115293599|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116624437|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116624437|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|151|591050309|Female|Germ Cell Tumors|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|39|591050309|Female|Germ Cell Tumors|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|116968997|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116968997|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|119269696|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119269696|Female|Germ Cell Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|24|120497646|Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|120497646|Female|Germ Cell Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|121775584|Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|121775584|Female|Germ Cell Tumors|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4085|109112165|Female|Glioblastoma|2004|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4154|110320645|Female|Glioblastoma|2005|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.5|3.7|3.6|Malignant|4290|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4366|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4403|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4465|115293599|Female|Glioblastoma|2009|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116624437|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4605|116624437|Female|Glioblastoma|2010|3.8|4.1|3.9
20+|~|~|~|Benign/Borderline|~|591050309|Female|Glioblastoma|2010-2014|~|~|~
20+|3.4|3.5|3.5|Malignant|23505|591050309|Female|Glioblastoma|2010-2014|3.9|4.0|4.0
20+|~|~|~|Benign/Borderline|~|116968997|Female|Glioblastoma|2011|~|~|~
20+|3.4|3.6|3.5|Malignant|4550|116968997|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|119269696|Female|Glioblastoma|2012|~|~|~
20+|3.5|3.7|3.6|Malignant|4846|119269696|Female|Glioblastoma|2012|3.9|4.2|4.1
20+|~|~|~|Benign/Borderline|~|120497646|Female|Glioblastoma|2013|~|~|~
20+|3.4|3.6|3.5|Malignant|4898|120497646|Female|Glioblastoma|2013|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|121775584|Female|Glioblastoma|2014|~|~|~
20+|3.3|3.5|3.4|Malignant|4739|121775584|Female|Glioblastoma|2014|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|421|109112165|Female|Glioma malignant, NOS|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|389|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|395|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|409|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|436|114027722|Female|Glioma malignant, NOS|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|512|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116624437|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|406|116624437|Female|Glioma malignant, NOS|2010|0.3|0.4|0.3
20+|0.0|0.0|0.0|Benign/Borderline|70|591050309|Female|Glioma malignant, NOS|2010-2014|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|2120|591050309|Female|Glioma malignant, NOS|2010-2014|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116968997|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|437|116968997|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119269696|Female|Glioma malignant, NOS|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|426|119269696|Female|Glioma malignant, NOS|2012|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|.|120497646|Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|449|120497646|Female|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|.|121775584|Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|416|121775584|Female|Glioma malignant, NOS|2014|0.3|0.4|0.3
20+|0.2|0.2|0.2|Benign/Borderline|205|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|221|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|215|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|232|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|116624437|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116624437|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1142|591050309|Female|Hemangioblastoma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|591050309|Female|Hemangioblastoma|2010-2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|116968997|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116968997|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|250|119269696|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119269696|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|228|120497646|Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120497646|Female|Hemangioblastoma|2013|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|208|121775584|Female|Hemangioblastoma|2014|0.1|0.2|0.2
20+|~|~|~|Malignant|~|121775584|Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|279|110320645|Female|Hemangioma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|303|111567226|Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|360|112783993|Female|Hemangioma|2007|0.3|0.4|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|452|114027722|Female|Hemangioma|2008|0.4|0.4|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|500|115293599|Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|642|116624437|Female|Hemangioma|2010|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116624437|Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|3251|591050309|Female|Hemangioma|2010-2014|0.5|0.6|0.6
20+|~|~|~|Malignant|~|591050309|Female|Hemangioma|2010-2014|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|690|116968997|Female|Hemangioma|2011|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116968997|Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|678|119269696|Female|Hemangioma|2012|0.5|0.6|0.6
20+|~|~|~|Malignant|~|119269696|Female|Hemangioma|2012|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|676|120497646|Female|Hemangioma|2013|0.5|0.6|0.6
20+|~|~|~|Malignant|~|120497646|Female|Hemangioma|2013|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|573|121775584|Female|Hemangioma|2014|0.4|0.5|0.5
20+|~|~|~|Malignant|~|121775584|Female|Hemangioma|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116624437|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|23|116624437|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|591050309|Female|Local Extensions from Regional Tumors|2010-2014|~|~|~
20+|0.0|0.0|0.0|Malignant|104|591050309|Female|Local Extensions from Regional Tumors|2010-2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116968997|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|116968997|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119269696|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|20|119269696|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120497646|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Malignant|~|120497646|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|121775584|Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|25|121775584|Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|593|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|661|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|674|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|637|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|699|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|661|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116624437|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|750|116624437|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|591050309|Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|~|~|~
20+|0.5|0.6|0.6|Malignant|3680|591050309|Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116968997|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.6|Malignant|713|116968997|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|119269696|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|698|119269696|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|120497646|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|737|120497646|Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|121775584|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|805|121775584|Female|Lymphomas and Hematopoietic Neoplasms|2014|0.6|0.7|0.7
20+|11.8|12.2|12.0|Benign/Borderline|13927|109112165|Female|Meningioma|2004|12.6|13.0|12.8
20+|0.2|0.3|0.2|Malignant|271|109112165|Female|Meningioma|2004|0.2|0.3|0.2
20+|13.3|13.7|13.5|Benign/Borderline|15943|110320645|Female|Meningioma|2005|14.2|14.7|14.5
20+|0.2|0.3|0.2|Malignant|278|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|13.9|14.3|14.1|Benign/Borderline|16933|111567226|Female|Meningioma|2006|14.9|15.4|15.2
20+|0.2|0.2|0.2|Malignant|253|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.3|14.8|14.5|Benign/Borderline|17764|112783993|Female|Meningioma|2007|15.5|16.0|15.8
20+|0.2|0.2|0.2|Malignant|266|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|15.0|15.4|15.2|Benign/Borderline|18907|114027722|Female|Meningioma|2008|16.3|16.8|16.6
20+|0.2|0.2|0.2|Malignant|216|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|15.9|16.3|16.1|Benign/Borderline|20397|115293599|Female|Meningioma|2009|17.4|17.9|17.7
20+|0.1|0.2|0.2|Malignant|201|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|15.2|15.7|15.5|Benign/Borderline|19882|116624437|Female|Meningioma|2010|16.8|17.3|17.0
20+|0.1|0.2|0.2|Malignant|204|116624437|Female|Meningioma|2010|0.2|0.2|0.2
20+|15.3|15.5|15.4|Benign/Borderline|101627|591050309|Female|Meningioma|2010-2014|17.1|17.3|17.2
20+|0.1|0.2|0.2|Malignant|1011|591050309|Female|Meningioma|2010-2014|0.2|0.2|0.2
20+|15.3|15.8|15.5|Benign/Borderline|20096|116968997|Female|Meningioma|2011|16.9|17.4|17.2
20+|0.1|0.2|0.1|Malignant|181|116968997|Female|Meningioma|2011|0.1|0.2|0.2
20+|15.3|15.7|15.5|Benign/Borderline|20606|119269696|Female|Meningioma|2012|17.0|17.5|17.3
20+|0.1|0.2|0.2|Malignant|200|119269696|Female|Meningioma|2012|0.1|0.2|0.2
20+|15.2|15.6|15.4|Benign/Borderline|20721|120497646|Female|Meningioma|2013|17.0|17.4|17.2
20+|0.1|0.2|0.2|Malignant|220|120497646|Female|Meningioma|2013|0.2|0.2|0.2
20+|14.9|15.3|15.1|Benign/Borderline|20782|121775584|Female|Meningioma|2014|16.8|17.3|17.1
20+|0.1|0.2|0.1|Malignant|207|121775584|Female|Meningioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|195|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.2|Malignant|238|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|273|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.3|0.2|Malignant|241|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|262|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.3|Malignant|284|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116624437|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|268|116624437|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|591050309|Female|Mixed glioma|2010-2014|~|~|~
20+|0.2|0.2|0.2|Malignant|1210|591050309|Female|Mixed glioma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|116968997|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|268|116968997|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|119269696|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|237|119269696|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|120497646|Female|Mixed glioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|247|120497646|Female|Mixed glioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|121775584|Female|Mixed glioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|197|121775584|Female|Mixed glioma|2014|0.1|0.2|0.2
20+|0.5|0.6|0.6|Benign/Borderline|684|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|702|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|864|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|718|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|795|111567226|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|722|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|831|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|648|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|824|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|751|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|906|115293599|Female|Neoplasm, unspecified|2009|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|785|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|813|116624437|Female|Neoplasm, unspecified|2010|0.7|0.7|0.7
20+|0.4|0.5|0.5|Malignant|650|116624437|Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|4013|591050309|Female|Neoplasm, unspecified|2010-2014|0.7|0.7|0.7
20+|0.4|0.5|0.5|Malignant|3269|591050309|Female|Neoplasm, unspecified|2010-2014|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|814|116968997|Female|Neoplasm, unspecified|2011|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|637|116968997|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|831|119269696|Female|Neoplasm, unspecified|2012|0.7|0.7|0.7
20+|0.4|0.5|0.5|Malignant|663|119269696|Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|773|120497646|Female|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.4|0.5|0.5|Malignant|659|120497646|Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|801|121775584|Female|Neoplasm, unspecified|2014|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|703|121775584|Female|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|2.2|2.3|2.3|Benign/Borderline|2520|109112165|Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|2784|110320645|Female|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2901|111567226|Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2895|112783993|Female|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2995|114027722|Female|Nerve sheath, benign and malignant|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3153|115293599|Female|Nerve sheath, benign and malignant|2009|2.6|2.8|2.7
20+|~|~|~|Malignant|~|115293599|Female|Nerve sheath, benign and malignant|2009|~|~|~
20+|2.3|2.5|2.4|Benign/Borderline|2926|116624437|Female|Nerve sheath, benign and malignant|2010|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|116624437|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|16046|591050309|Female|Nerve sheath, benign and malignant|2010-2014|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|105|591050309|Female|Nerve sheath, benign and malignant|2010-2014|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|3146|116968997|Female|Nerve sheath, benign and malignant|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|116968997|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3289|119269696|Female|Nerve sheath, benign and malignant|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|25|119269696|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|3377|120497646|Female|Nerve sheath, benign and malignant|2013|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|23|120497646|Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3344|121775584|Female|Nerve sheath, benign and malignant|2014|2.7|2.8|2.7
20+|~|~|~|Malignant|~|121775584|Female|Nerve sheath, benign and malignant|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116624437|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116624437|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|591050309|Female|Neuroepithelial|2010-2014|~|~|~
20+|0.0|0.0|0.0|Malignant|119|591050309|Female|Neuroepithelial|2010-2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116968997|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|23|116968997|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119269696|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|119269696|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120497646|Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|21|120497646|Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121775584|Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121775584|Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|153|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|182|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|186|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|201|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|220|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|245|116624437|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|.|116624437|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1090|591050309|Female|Neuronal/glial, neuronal|2010-2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|83|591050309|Female|Neuronal/glial, neuronal|2010-2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|236|116968997|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|116968997|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|208|119269696|Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|119269696|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|176|120497646|Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|120497646|Female|Neuronal/glial, neuronal|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|121775584|Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121775584|Female|Neuronal/glial, neuronal|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|351|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|354|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|375|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|368|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|357|114027722|Female|Oligodendroglioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|361|115293599|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116624437|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|327|116624437|Female|Oligodendroglioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|591050309|Female|Oligodendroglioma|2010-2014|~|~|~
20+|0.3|0.3|0.3|Malignant|1542|591050309|Female|Oligodendroglioma|2010-2014|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116968997|Female|Oligodendroglioma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|308|116968997|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119269696|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|291|119269696|Female|Oligodendroglioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|120497646|Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|332|120497646|Female|Oligodendroglioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|121775584|Female|Oligodendroglioma|2014|~|~|~
20+|0.2|0.3|0.3|Malignant|295|121775584|Female|Oligodendroglioma|2014|0.2|0.3|0.2
20+|0.0|0.1|0.1|Benign/Borderline|67|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|86|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|52|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|94|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|116624437|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|116624437|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|472|591050309|Female|Other mesenchymal|2010-2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|171|591050309|Female|Other mesenchymal|2010-2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|89|116968997|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|116968997|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|110|119269696|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|119269696|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|120497646|Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|120497646|Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|85|121775584|Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|121775584|Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|124|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|149|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|148|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|160|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116624437|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|166|116624437|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|591050309|Female|Pilocytic astrocytoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|736|591050309|Female|Pilocytic astrocytoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116968997|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|159|116968997|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119269696|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|122|119269696|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120497646|Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|154|120497646|Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121775584|Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|139|121775584|Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|.|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|.|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|.|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|.|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|114027722|Female|Pineal parenchymal|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|.|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|.|116624437|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|116624437|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|204|591050309|Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|120|591050309|Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|42|116968997|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|116968997|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|119269696|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|119269696|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|.|120497646|Female|Pineal parenchymal|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|34|120497646|Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|121775584|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|121775584|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|3.5|3.8|3.7|Benign/Borderline|3978|109112165|Female|Pituitary|2004|3.5|3.8|3.6
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|4.1|4.4|4.2|Benign/Borderline|4646|110320645|Female|Pituitary|2005|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|.|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.5|4.8|4.6|Benign/Borderline|5130|111567226|Female|Pituitary|2006|4.5|4.7|4.6
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.6|4.8|4.7|Benign/Borderline|5271|112783993|Female|Pituitary|2007|4.5|4.8|4.7
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|5629|114027722|Female|Pituitary|2008|4.8|5.1|4.9
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|5.4|5.6|5.5|Benign/Borderline|6260|115293599|Female|Pituitary|2009|5.3|5.6|5.4
20+|~|~|~|Malignant|~|115293599|Female|Pituitary|2009|~|~|~
20+|5.2|5.5|5.4|Benign/Borderline|6164|116624437|Female|Pituitary|2010|5.2|5.4|5.3
20+|~|~|~|Malignant|~|116624437|Female|Pituitary|2010|~|~|~
20+|5.4|5.5|5.4|Benign/Borderline|31503|591050309|Female|Pituitary|2010-2014|5.3|5.4|5.3
20+|0.0|0.0|0.0|Malignant|70|591050309|Female|Pituitary|2010-2014|0.0|0.0|0.0
20+|5.3|5.6|5.5|Benign/Borderline|6277|116968997|Female|Pituitary|2011|5.2|5.5|5.4
20+|~|~|~|Malignant|~|116968997|Female|Pituitary|2011|~|~|~
20+|5.5|5.8|5.6|Benign/Borderline|6584|119269696|Female|Pituitary|2012|5.4|5.7|5.5
20+|~|~|~|Malignant|~|119269696|Female|Pituitary|2012|~|~|~
20+|5.2|5.5|5.3|Benign/Borderline|6382|120497646|Female|Pituitary|2013|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|16|120497646|Female|Pituitary|2013|0.0|0.0|0.0
20+|5.0|5.3|5.2|Benign/Borderline|6206|121775584|Female|Pituitary|2014|5.0|5.2|5.1
20+|~|~|~|Malignant|~|121775584|Female|Pituitary|2014|~|~|~
20+|19.2|19.7|19.5|Benign/Borderline|22210|109112165|Female|Total|2004|20.1|20.6|20.4
20+|7.4|7.8|7.6|Malignant|8717|109112165|Female|Total|2004|7.8|8.2|8.0
20+|21.8|22.3|22.0|Benign/Borderline|25490|110320645|Female|Total|2005|22.8|23.4|23.1
20+|7.5|7.8|7.6|Malignant|8890|110320645|Female|Total|2005|7.9|8.2|8.1
20+|22.8|23.4|23.1|Benign/Borderline|27090|111567226|Female|Total|2006|24.0|24.6|24.3
20+|7.4|7.8|7.6|Malignant|8964|111567226|Female|Total|2006|7.9|8.2|8.0
20+|23.3|23.9|23.6|Benign/Borderline|28154|112783993|Female|Total|2007|24.7|25.3|25.0
20+|7.4|7.7|7.6|Malignant|9042|112783993|Female|Total|2007|7.9|8.2|8.0
20+|24.4|25.0|24.7|Benign/Borderline|29890|114027722|Female|Total|2008|25.9|26.5|26.2
20+|7.4|7.7|7.5|Malignant|9195|114027722|Female|Total|2008|7.9|8.2|8.1
20+|26.0|26.6|26.3|Benign/Borderline|32323|115293599|Female|Total|2009|27.7|28.3|28.0
20+|7.4|7.7|7.5|Malignant|9338|115293599|Female|Total|2009|7.9|8.3|8.1
20+|25.1|25.6|25.3|Benign/Borderline|31557|116624437|Female|Total|2010|26.8|27.4|27.1
20+|7.2|7.5|7.3|Malignant|9277|116624437|Female|Total|2010|7.8|8.1|8.0
20+|25.4|25.6|25.5|Benign/Borderline|162013|591050309|Female|Total|2010-2014|27.3|27.5|27.4
20+|7.1|7.2|7.2|Malignant|46328|591050309|Female|Total|2010-2014|7.8|7.9|7.8
20+|25.5|26.0|25.7|Benign/Borderline|32154|116968997|Female|Total|2011|27.2|27.8|27.5
20+|7.0|7.3|7.1|Malignant|9085|116968997|Female|Total|2011|7.6|7.9|7.8
20+|25.6|26.1|25.9|Benign/Borderline|33126|119269696|Female|Total|2012|27.5|28.1|27.8
20+|7.1|7.4|7.2|Malignant|9402|119269696|Female|Total|2012|7.7|8.0|7.9
20+|25.1|25.7|25.4|Benign/Borderline|33027|120497646|Female|Total|2013|27.1|27.7|27.4
20+|7.0|7.3|7.2|Malignant|9544|120497646|Female|Total|2013|7.8|8.1|7.9
20+|24.6|25.1|24.8|Benign/Borderline|32794|121775584|Female|Total|2014|26.6|27.2|26.9
20+|6.7|7.0|6.9|Malignant|9305|121775584|Female|Total|2014|7.5|7.8|7.6
20+|2.2|2.3|2.3|Benign/Borderline|2520|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|2787|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2902|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2896|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2997|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3156|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.6|2.8|2.7
20+|~|~|~|Malignant|~|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
20+|2.3|2.5|2.4|Benign/Borderline|2929|116624437|Female|Tumors of Cranial and Spinal Nerves|2010|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|116624437|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|16056|591050309|Female|Tumors of Cranial and Spinal Nerves|2010-2014|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|105|591050309|Female|Tumors of Cranial and Spinal Nerves|2010-2014|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|3148|116968997|Female|Tumors of Cranial and Spinal Nerves|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|116968997|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3289|119269696|Female|Tumors of Cranial and Spinal Nerves|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|25|119269696|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|3378|120497646|Female|Tumors of Cranial and Spinal Nerves|2013|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|23|120497646|Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3348|121775584|Female|Tumors of Cranial and Spinal Nerves|2014|2.7|2.8|2.7
20+|~|~|~|Malignant|~|121775584|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|377|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.0|6.3|6.2|Malignant|7037|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.4
20+|0.4|0.4|0.4|Benign/Borderline|439|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7122|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|478|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7210|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|476|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7371|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|482|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|7396|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|507|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7594|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.4|6.7|6.6
20+|0.4|0.5|0.5|Benign/Borderline|540|116624437|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.2|6.0|Malignant|7564|116624437|Female|Tumors of Neuroepthelial Tissue|2010|6.3|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|2674|591050309|Female|Tumors of Neuroepthelial Tissue|2010-2014|0.4|0.5|0.5
20+|5.8|6.0|5.9|Malignant|37841|591050309|Female|Tumors of Neuroepthelial Tissue|2010-2014|6.3|6.5|6.4
20+|0.4|0.5|0.5|Benign/Borderline|550|116968997|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.8|6.1|5.9|Malignant|7456|116968997|Female|Tumors of Neuroepthelial Tissue|2011|6.2|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|525|119269696|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.4
20+|5.8|6.1|6.0|Malignant|7732|119269696|Female|Tumors of Neuroepthelial Tissue|2012|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|511|120497646|Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.4
20+|5.8|6.1|5.9|Malignant|7821|120497646|Female|Tumors of Neuroepthelial Tissue|2013|6.3|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|552|121775584|Female|Tumors of Neuroepthelial Tissue|2014|0.4|0.5|0.5
20+|5.5|5.7|5.6|Malignant|7485|121775584|Female|Tumors of Neuroepthelial Tissue|2014|6.0|6.3|6.1
20+|3.7|4.0|3.8|Benign/Borderline|4179|109112165|Female|Tumors of Sellar Region|2004|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|4829|110320645|Female|Tumors of Sellar Region|2005|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|.|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|5329|111567226|Female|Tumors of Sellar Region|2006|4.6|4.9|4.8
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|4.8|5.0|4.9|Benign/Borderline|5488|112783993|Female|Tumors of Sellar Region|2007|4.7|5.0|4.9
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|5.0|5.3|5.2|Benign/Borderline|5850|114027722|Female|Tumors of Sellar Region|2008|5.0|5.3|5.1
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.5|5.8|5.7|Benign/Borderline|6487|115293599|Female|Tumors of Sellar Region|2009|5.5|5.8|5.6
20+|0.0|0.0|0.0|Malignant|.|115293599|Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.4|5.7|5.6|Benign/Borderline|6400|116624437|Female|Tumors of Sellar Region|2010|5.4|5.6|5.5
20+|~|~|~|Malignant|~|116624437|Female|Tumors of Sellar Region|2010|~|~|~
20+|5.5|5.7|5.6|Benign/Borderline|32610|591050309|Female|Tumors of Sellar Region|2010-2014|5.5|5.6|5.5
20+|0.0|0.0|0.0|Malignant|73|591050309|Female|Tumors of Sellar Region|2010-2014|0.0|0.0|0.0
20+|5.5|5.8|5.6|Benign/Borderline|6493|116968997|Female|Tumors of Sellar Region|2011|5.4|5.7|5.6
20+|~|~|~|Malignant|~|116968997|Female|Tumors of Sellar Region|2011|~|~|~
20+|5.7|6.0|5.8|Benign/Borderline|6802|119269696|Female|Tumors of Sellar Region|2012|5.6|5.8|5.7
20+|~|~|~|Malignant|~|119269696|Female|Tumors of Sellar Region|2012|~|~|~
20+|5.4|5.7|5.5|Benign/Borderline|6617|120497646|Female|Tumors of Sellar Region|2013|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|17|120497646|Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.2|5.5|5.3|Benign/Borderline|6413|121775584|Female|Tumors of Sellar Region|2014|5.1|5.4|5.3
20+|~|~|~|Malignant|~|121775584|Female|Tumors of Sellar Region|2014|~|~|~
20+|12.0|12.4|12.2|Benign/Borderline|14199|109112165|Female|Tumors of the Meninges|2004|12.8|13.2|13.0
20+|0.2|0.3|0.3|Malignant|297|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.5|14.0|13.8|Benign/Borderline|16250|110320645|Female|Tumors of the Meninges|2005|14.5|15.0|14.7
20+|0.2|0.3|0.3|Malignant|305|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|14.1|14.6|14.3|Benign/Borderline|17240|111567226|Female|Tumors of the Meninges|2006|15.2|15.7|15.5
20+|0.2|0.3|0.2|Malignant|284|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.6|15.0|14.8|Benign/Borderline|18062|112783993|Female|Tumors of the Meninges|2007|15.8|16.2|16.0
20+|0.2|0.3|0.2|Malignant|305|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|15.3|15.7|15.5|Benign/Borderline|19246|114027722|Female|Tumors of the Meninges|2008|16.6|17.1|16.9
20+|0.2|0.2|0.2|Malignant|268|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|16.2|16.6|16.4|Benign/Borderline|20723|115293599|Female|Tumors of the Meninges|2009|17.7|18.2|18.0
20+|0.2|0.2|0.2|Malignant|228|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|15.5|15.9|15.7|Benign/Borderline|20197|116624437|Female|Tumors of the Meninges|2010|17.1|17.6|17.3
20+|0.2|0.2|0.2|Malignant|239|116624437|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|15.6|15.8|15.7|Benign/Borderline|103241|591050309|Female|Tumors of the Meninges|2010-2014|17.4|17.6|17.5
20+|0.2|0.2|0.2|Malignant|1191|591050309|Female|Tumors of the Meninges|2010-2014|0.2|0.2|0.2
20+|15.6|16.0|15.8|Benign/Borderline|20422|116968997|Female|Tumors of the Meninges|2011|17.2|17.7|17.5
20+|0.1|0.2|0.2|Malignant|211|116968997|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|15.6|16.0|15.8|Benign/Borderline|20966|119269696|Female|Tumors of the Meninges|2012|17.3|17.8|17.6
20+|0.2|0.2|0.2|Malignant|236|119269696|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|15.4|15.9|15.7|Benign/Borderline|21044|120497646|Female|Tumors of the Meninges|2013|17.2|17.7|17.5
20+|0.2|0.2|0.2|Malignant|263|120497646|Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|15.2|15.6|15.4|Benign/Borderline|21075|121775584|Female|Tumors of the Meninges|2014|17.1|17.5|17.3
20+|0.2|0.2|0.2|Malignant|243|121775584|Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|917|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|708|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1147|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|722|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|0.9|Benign/Borderline|1106|111567226|Female|Unclassified Tumors|2006|0.9|1.1|1.0
20+|0.5|0.6|0.6|Malignant|727|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.1|1.0|Benign/Borderline|1195|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|651|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1282|114027722|Female|Unclassified Tumors|2008|1.1|1.2|1.1
20+|0.5|0.6|0.6|Malignant|766|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.2|1.2|Benign/Borderline|1407|115293599|Female|Unclassified Tumors|2009|1.2|1.3|1.2
20+|0.5|0.6|0.6|Malignant|792|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.1|1.2|1.2|Benign/Borderline|1458|116624437|Female|Unclassified Tumors|2010|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|657|116624437|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|7277|591050309|Female|Unclassified Tumors|2010-2014|1.2|1.3|1.2
20+|0.4|0.5|0.5|Malignant|3295|591050309|Female|Unclassified Tumors|2010-2014|0.5|0.6|0.6
20+|1.2|1.3|1.2|Benign/Borderline|1508|116968997|Female|Unclassified Tumors|2011|1.2|1.4|1.3
20+|0.4|0.5|0.5|Malignant|641|116968997|Female|Unclassified Tumors|2011|0.5|0.6|0.5
20+|1.1|1.2|1.2|Benign/Borderline|1510|119269696|Female|Unclassified Tumors|2012|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|668|119269696|Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|1453|120497646|Female|Unclassified Tumors|2013|1.1|1.3|1.2
20+|0.4|0.5|0.5|Malignant|663|120497646|Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1375|121775584|Female|Unclassified Tumors|2014|1.1|1.2|1.1
20+|0.4|0.5|0.5|Malignant|709|121775584|Female|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.0|0.1|0.0|Benign/Borderline|53|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|48|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|62|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|56|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|115293599|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|68|116624437|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|116624437|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|426|591050309|Female|Unique astrocytoma variants|2010-2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|144|591050309|Female|Unique astrocytoma variants|2010-2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|80|116968997|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|116968997|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|98|119269696|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|119269696|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|91|120497646|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|120497646|Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|90|121775584|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|121775584|Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|104488268|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|.|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109536975|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109536975|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|556321335|Male|All other|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|109|556321335|Male|All other|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|.|109915911|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|109915911|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112332773|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|.|112332773|Male|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|.|113652712|Male|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|113652712|Male|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114975678|Male|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|24|114975678|Male|All other|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|670|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|695|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|697|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|668|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|709|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|710|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109536975|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|698|109536975|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|556321335|Male|Anaplastic astrocytoma|2010-2014|~|~|~
20+|0.6|0.7|0.7|Malignant|3678|556321335|Male|Anaplastic astrocytoma|2010-2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109915911|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|699|109915911|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112332773|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|746|112332773|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113652712|Male|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.7|0.7|Malignant|779|113652712|Male|Anaplastic astrocytoma|2013|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|114975678|Male|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|774|114975678|Male|Anaplastic astrocytoma|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|207|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|207|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|213|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|180|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|188|106947980|Male|Anaplastic oligodendroglioma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|184|108197539|Male|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109536975|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|188|109536975|Male|Anaplastic oligodendroglioma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|556321335|Male|Anaplastic oligodendroglioma|2010-2014|~|~|~
20+|0.2|0.2|0.2|Malignant|956|556321335|Male|Anaplastic oligodendroglioma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109915911|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|176|109915911|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112332773|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|183|112332773|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113652712|Male|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|216|113652712|Male|Anaplastic oligodendroglioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114975678|Male|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|198|114975678|Male|Anaplastic oligodendroglioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|633|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|628|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|646|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|622|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|620|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|570|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109536975|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|608|109536975|Male|Astrocytoma, NOS|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|556321335|Male|Astrocytoma, NOS|2010-2014|~|~|~
20+|0.5|0.5|0.5|Malignant|2843|556321335|Male|Astrocytoma, NOS|2010-2014|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|109915911|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|568|109915911|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|112332773|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|543|112332773|Male|Astrocytoma, NOS|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113652712|Male|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.5|0.5|Malignant|550|113652712|Male|Astrocytoma, NOS|2013|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114975678|Male|Astrocytoma, NOS|2014|~|~|~
20+|0.5|0.5|0.5|Malignant|579|114975678|Male|Astrocytoma, NOS|2014|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|24|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|109536975|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109536975|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|171|556321335|Male|Choroid plexus|2010-2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|556321335|Male|Choroid plexus|2010-2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|109915911|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109915911|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|112332773|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112332773|Male|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|113652712|Male|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113652712|Male|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|114975678|Male|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114975678|Male|Choroid plexus|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|181|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|230|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|189|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|195|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|197|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|199|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|109536975|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109536975|Male|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1015|556321335|Male|Craniopharyngioma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|556321335|Male|Craniopharyngioma|2010-2014|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|190|109915911|Male|Craniopharyngioma|2011|0.1|0.2|0.2
20+|~|~|~|Malignant|~|109915911|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|214|112332773|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112332773|Male|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|113652712|Male|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113652712|Male|Craniopharyngioma|2013|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|196|114975678|Male|Craniopharyngioma|2014|0.1|0.2|0.2
20+|~|~|~|Malignant|~|114975678|Male|Craniopharyngioma|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|143|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|206|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109536975|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|187|109536975|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|556321335|Male|Diffuse astrocytoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|601|556321335|Male|Diffuse astrocytoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109915911|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|134|109915911|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112332773|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|113|112332773|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113652712|Male|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|102|113652712|Male|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114975678|Male|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|69|114975678|Male|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|98|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|104|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|96|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|123|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|132|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109536975|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|124|109536975|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|556321335|Male|Embryonal/primitive/medulloblastoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|535|556321335|Male|Embryonal/primitive/medulloblastoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109915911|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|109915911|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112332773|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112332773|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113652712|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|96|113652712|Male|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114975678|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|108|114975678|Male|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|148|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|158|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|109536975|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109536975|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|771|556321335|Male|Ependymoma variants|2010-2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|.|556321335|Male|Ependymoma variants|2010-2014|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|146|109915911|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109915911|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|161|112332773|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|112332773|Male|Ependymoma variants|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|154|113652712|Male|Ependymoma variants|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|113652712|Male|Ependymoma variants|2013|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|160|114975678|Male|Ependymoma variants|2014|0.1|0.2|0.1
20+|~|~|~|Malignant|~|114975678|Male|Ependymoma variants|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|298|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|298|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|287|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|286|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|321|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|333|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109536975|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|324|109536975|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|51|556321335|Male|Ependymoma/anaplastic ependymoma|2010-2014|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1533|556321335|Male|Ependymoma/anaplastic ependymoma|2010-2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109915911|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|290|109915911|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112332773|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|321|112332773|Male|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113652712|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|297|113652712|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|.|114975678|Male|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|309|114975678|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|.|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|.|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|.|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|.|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|32|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|.|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|.|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|109536975|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|.|109536975|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|128|556321335|Male|Germ Cell Tumors|2010-2014|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|257|556321335|Male|Germ Cell Tumors|2010-2014|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|109915911|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|.|109915911|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|112332773|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|.|112332773|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|113652712|Male|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|.|113652712|Male|Germ Cell Tumors|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|114975678|Male|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|.|114975678|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5463|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.4|5.7|5.6|Malignant|5528|103190694|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5508|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5809|105697783|Male|Glioblastoma|2007|5.4|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.6|Malignant|5995|106947980|Male|Glioblastoma|2008|5.5|5.7|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.6|Malignant|6002|108197539|Male|Glioblastoma|2009|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|109536975|Male|Glioblastoma|2010|~|~|~
20+|5.3|5.6|5.5|Malignant|6103|109536975|Male|Glioblastoma|2010|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|556321335|Male|Glioblastoma|2010-2014|~|~|~
20+|5.5|5.6|5.5|Malignant|31961|556321335|Male|Glioblastoma|2010-2014|5.7|5.8|5.7
20+|~|~|~|Benign/Borderline|~|109915911|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.7|5.5|Malignant|6231|109915911|Male|Glioblastoma|2011|5.5|5.8|5.7
20+|~|~|~|Benign/Borderline|~|112332773|Male|Glioblastoma|2012|~|~|~
20+|5.4|5.7|5.6|Malignant|6507|112332773|Male|Glioblastoma|2012|5.7|5.9|5.8
20+|~|~|~|Benign/Borderline|~|113652712|Male|Glioblastoma|2013|~|~|~
20+|5.4|5.7|5.5|Malignant|6612|113652712|Male|Glioblastoma|2013|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|114975678|Male|Glioblastoma|2014|~|~|~
20+|5.4|5.7|5.5|Malignant|6723|114975678|Male|Glioblastoma|2014|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|424|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|440|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|439|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|460|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|.|106947980|Male|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|473|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|450|108197539|Male|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109536975|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|405|109536975|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|65|556321335|Male|Glioma malignant, NOS|2010-2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2276|556321335|Male|Glioma malignant, NOS|2010-2014|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109915911|Male|Glioma malignant, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|480|109915911|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112332773|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|481|112332773|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113652712|Male|Glioma malignant, NOS|2013|~|~|~
20+|0.4|0.4|0.4|Malignant|444|113652712|Male|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114975678|Male|Glioma malignant, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|479|114975678|Male|Glioma malignant, NOS|2014|0.4|0.5|0.4
20+|0.2|0.3|0.2|Benign/Borderline|245|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|283|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|276|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|253|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|289|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|270|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.2
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|301|109536975|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109536975|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|1358|556321335|Male|Hemangioblastoma|2010-2014|0.2|0.3|0.2
20+|~|~|~|Malignant|~|556321335|Male|Hemangioblastoma|2010-2014|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|264|109915911|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|109915911|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|272|112332773|Male|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|112332773|Male|Hemangioblastoma|2012|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|270|113652712|Male|Hemangioblastoma|2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|113652712|Male|Hemangioblastoma|2013|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|258|114975678|Male|Hemangioblastoma|2014|0.2|0.3|0.2
20+|~|~|~|Malignant|~|114975678|Male|Hemangioblastoma|2014|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|135|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|192|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|227|104488268|Male|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|262|105697783|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|310|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|413|108197539|Male|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|426|109536975|Male|Hemangioma|2010|0.4|0.4|0.4
20+|~|~|~|Malignant|~|109536975|Male|Hemangioma|2010|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2335|556321335|Male|Hemangioma|2010-2014|0.4|0.4|0.4
20+|~|~|~|Malignant|~|556321335|Male|Hemangioma|2010-2014|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|486|109915911|Male|Hemangioma|2011|0.4|0.5|0.4
20+|~|~|~|Malignant|~|109915911|Male|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|489|112332773|Male|Hemangioma|2012|0.4|0.5|0.4
20+|~|~|~|Malignant|~|112332773|Male|Hemangioma|2012|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|493|113652712|Male|Hemangioma|2013|0.4|0.5|0.4
20+|~|~|~|Malignant|~|113652712|Male|Hemangioma|2013|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|445|114975678|Male|Hemangioma|2014|0.4|0.4|0.4
20+|~|~|~|Malignant|~|114975678|Male|Hemangioma|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|24|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|34|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|29|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109536975|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|29|109536975|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|556321335|Male|Local Extensions from Regional Tumors|2010-2014|~|~|~
20+|0.0|0.0|0.0|Malignant|132|556321335|Male|Local Extensions from Regional Tumors|2010-2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109915911|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|109915911|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112332773|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|29|112332773|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113652712|Male|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|.|113652712|Male|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114975678|Male|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|26|114975678|Male|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|748|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|776|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.8
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|757|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|736|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.8|Malignant|772|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|759|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|109536975|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|756|109536975|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|556321335|Male|Lymphomas and Hematopoietic Neoplasms|2010-2014|~|~|~
20+|0.7|0.7|0.7|Malignant|3828|556321335|Male|Lymphomas and Hematopoietic Neoplasms|2010-2014|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109915911|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|799|109915911|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|112332773|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|755|112332773|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113652712|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.7|0.6|Malignant|730|113652712|Male|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|114975678|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|808|114975678|Male|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.8|0.7
20+|5.0|5.3|5.2|Benign/Borderline|4837|101938779|Male|Meningioma|2004|4.6|4.9|4.7
20+|0.2|0.2|0.2|Malignant|169|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.5|5.8|5.7|Benign/Borderline|5395|103190694|Male|Meningioma|2005|5.1|5.4|5.2
20+|0.1|0.2|0.2|Malignant|157|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.8|6.1|6.0|Benign/Borderline|5794|104488268|Male|Meningioma|2006|5.4|5.7|5.5
20+|0.1|0.2|0.2|Malignant|151|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|5.9|6.2|6.1|Benign/Borderline|5992|105697783|Male|Meningioma|2007|5.5|5.8|5.7
20+|0.1|0.2|0.2|Malignant|177|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.3|6.6|6.5|Benign/Borderline|6550|106947980|Male|Meningioma|2008|6.0|6.3|6.1
20+|0.1|0.2|0.1|Malignant|147|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.7|7.0|6.9|Benign/Borderline|7055|108197539|Male|Meningioma|2009|6.4|6.7|6.5
20+|0.1|0.2|0.1|Malignant|151|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.5|6.9|6.7|Benign/Borderline|7037|109536975|Male|Meningioma|2010|6.3|6.6|6.4
20+|0.1|0.1|0.1|Malignant|120|109536975|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.6|6.8|6.7|Benign/Borderline|36601|556321335|Male|Meningioma|2010-2014|6.5|6.6|6.6
20+|0.1|0.1|0.1|Malignant|715|556321335|Male|Meningioma|2010-2014|0.1|0.1|0.1
20+|6.6|6.9|6.7|Benign/Borderline|7176|109915911|Male|Meningioma|2011|6.4|6.7|6.5
20+|0.1|0.2|0.1|Malignant|142|109915911|Male|Meningioma|2011|0.1|0.2|0.1
20+|6.4|6.7|6.6|Benign/Borderline|7263|112332773|Male|Meningioma|2012|6.3|6.6|6.5
20+|0.1|0.2|0.1|Malignant|146|112332773|Male|Meningioma|2012|0.1|0.2|0.1
20+|6.7|7.0|6.8|Benign/Borderline|7700|113652712|Male|Meningioma|2013|6.6|6.9|6.8
20+|0.1|0.2|0.1|Malignant|151|113652712|Male|Meningioma|2013|0.1|0.2|0.1
20+|6.4|6.7|6.6|Benign/Borderline|7596|114975678|Male|Meningioma|2014|6.5|6.8|6.6
20+|0.1|0.2|0.1|Malignant|156|114975678|Male|Meningioma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|292|101938779|Male|Mixed glioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|364|104488268|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|346|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|334|106947980|Male|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|391|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109536975|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|341|109536975|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|556321335|Male|Mixed glioma|2010-2014|~|~|~
20+|0.3|0.3|0.3|Malignant|1650|556321335|Male|Mixed glioma|2010-2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109915911|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|358|109915911|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112332773|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|327|112332773|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113652712|Male|Mixed glioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|372|113652712|Male|Mixed glioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114975678|Male|Mixed glioma|2014|~|~|~
20+|0.2|0.3|0.2|Malignant|262|114975678|Male|Mixed glioma|2014|0.2|0.3|0.2
20+|0.5|0.6|0.6|Benign/Borderline|500|101938779|Male|Neoplasm, unspecified|2004|0.4|0.5|0.5
20+|0.6|0.8|0.7|Malignant|615|101938779|Male|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|627|103190694|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|606|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|607|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|573|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|593|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|571|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|597|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|622|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|608|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|643|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|644|109536975|Male|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.6|0.6|Malignant|601|109536975|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|3186|556321335|Male|Neoplasm, unspecified|2010-2014|0.6|0.6|0.6
20+|0.6|0.6|0.6|Malignant|3026|556321335|Male|Neoplasm, unspecified|2010-2014|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|615|109915911|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|604|109915911|Male|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|686|112332773|Male|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|620|112332773|Male|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|671|113652712|Male|Neoplasm, unspecified|2013|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|607|113652712|Male|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.5|Benign/Borderline|582|114975678|Male|Neoplasm, unspecified|2014|0.5|0.5|0.5
20+|0.5|0.6|0.6|Malignant|638|114975678|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|2.2|2.3|2.3|Benign/Borderline|2297|101938779|Male|Nerve sheath, benign and malignant|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2646|103190694|Male|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2606|104488268|Male|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2690|105697783|Male|Nerve sheath, benign and malignant|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|19|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2642|106947980|Male|Nerve sheath, benign and malignant|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2803|108197539|Male|Nerve sheath, benign and malignant|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|.|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2805|109536975|Male|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|21|109536975|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|14820|556321335|Male|Nerve sheath, benign and malignant|2010-2014|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|101|556321335|Male|Nerve sheath, benign and malignant|2010-2014|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2852|109915911|Male|Nerve sheath, benign and malignant|2011|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|109915911|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3026|112332773|Male|Nerve sheath, benign and malignant|2012|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|25|112332773|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|3031|113652712|Male|Nerve sheath, benign and malignant|2013|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|113652712|Male|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3151|114975678|Male|Nerve sheath, benign and malignant|2014|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|.|114975678|Male|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109536975|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109536975|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|556321335|Male|Neuroepithelial|2010-2014|~|~|~
20+|0.0|0.0|0.0|Malignant|137|556321335|Male|Neuroepithelial|2010-2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109915911|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109915911|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112332773|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|112332773|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113652712|Male|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|27|113652712|Male|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114975678|Male|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|32|114975678|Male|Neuroepithelial|2014|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|159|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|.|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|187|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|197|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|183|105697783|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|216|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|232|109536975|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109536975|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1020|556321335|Male|Neuronal/glial, neuronal|2010-2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|92|556321335|Male|Neuronal/glial, neuronal|2010-2014|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|180|109915911|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|109915911|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|199|112332773|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|112332773|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|207|113652712|Male|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|.|113652712|Male|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|210|114975678|Male|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|.|114975678|Male|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|472|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|434|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|460|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|434|105697783|Male|Oligodendroglioma|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|400|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|460|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109536975|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|461|109536975|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|556321335|Male|Oligodendroglioma|2010-2014|~|~|~
20+|0.4|0.4|0.4|Malignant|2007|556321335|Male|Oligodendroglioma|2010-2014|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109915911|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|434|109915911|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112332773|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|362|112332773|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|113652712|Male|Oligodendroglioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|359|113652712|Male|Oligodendroglioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114975678|Male|Oligodendroglioma|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|397|114975678|Male|Oligodendroglioma|2014|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|80|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|71|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|34|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|38|105697783|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|98|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|45|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|109536975|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|109536975|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|380|556321335|Male|Other mesenchymal|2010-2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|193|556321335|Male|Other mesenchymal|2010-2014|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|65|109915911|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|42|109915911|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|90|112332773|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|112332773|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|73|113652712|Male|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|44|113652712|Male|Other mesenchymal|2013|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|77|114975678|Male|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|114975678|Male|Other mesenchymal|2014|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|150|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|159|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|143|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|136|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109536975|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|109536975|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|556321335|Male|Pilocytic astrocytoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|762|556321335|Male|Pilocytic astrocytoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109915911|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|170|109915911|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112332773|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|144|112332773|Male|Pilocytic astrocytoma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113652712|Male|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|143|113652712|Male|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114975678|Male|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|146|114975678|Male|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|.|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109536975|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109536975|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|86|556321335|Male|Pineal parenchymal|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|108|556321335|Male|Pineal parenchymal|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|109915911|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|109915911|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|112332773|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|112332773|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113652712|Male|Pineal parenchymal|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|36|113652712|Male|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|21|114975678|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|114975678|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|3.3|3.5|3.4|Benign/Borderline|3348|101938779|Male|Pituitary|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.5|3.8|3.7|Benign/Borderline|3690|103190694|Male|Pituitary|2005|3.5|3.7|3.6
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.7|4.0|3.9|Benign/Borderline|3953|104488268|Male|Pituitary|2006|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|.|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|4.0|4.3|4.1|Benign/Borderline|4323|105697783|Male|Pituitary|2007|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|.|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.3|4.6|4.5|Benign/Borderline|4718|106947980|Male|Pituitary|2008|4.3|4.5|4.4
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.5|4.8|4.6|Benign/Borderline|5023|108197539|Male|Pituitary|2009|4.5|4.8|4.6
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.5|4.8|4.7|Benign/Borderline|5134|109536975|Male|Pituitary|2010|4.6|4.8|4.7
20+|~|~|~|Malignant|~|109536975|Male|Pituitary|2010|~|~|~
20+|4.7|4.8|4.8|Benign/Borderline|26961|556321335|Male|Pituitary|2010-2014|4.8|4.9|4.8
20+|0.0|0.0|0.0|Malignant|101|556321335|Male|Pituitary|2010-2014|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|5209|109915911|Male|Pituitary|2011|4.6|4.9|4.7
20+|0.0|0.0|0.0|Malignant|.|109915911|Male|Pituitary|2011|0.0|0.0|0.0
20+|4.8|5.1|5.0|Benign/Borderline|5639|112332773|Male|Pituitary|2012|4.9|5.2|5.0
20+|0.0|0.0|0.0|Malignant|.|112332773|Male|Pituitary|2012|0.0|0.0|0.0
20+|4.7|5.0|4.9|Benign/Borderline|5613|113652712|Male|Pituitary|2013|4.8|5.1|4.9
20+|0.0|0.0|0.0|Malignant|25|113652712|Male|Pituitary|2013|0.0|0.0|0.0
20+|4.5|4.8|4.6|Benign/Borderline|5458|114975678|Male|Pituitary|2014|4.6|4.9|4.7
20+|0.0|0.0|0.0|Malignant|.|114975678|Male|Pituitary|2014|0.0|0.0|0.0
20+|12.2|12.6|12.4|Benign/Borderline|12089|101938779|Male|Total|2004|11.6|12.1|11.9
20+|10.6|11.1|10.9|Malignant|10619|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.6|14.1|13.8|Benign/Borderline|13683|103190694|Male|Total|2005|13.0|13.5|13.3
20+|10.7|11.1|10.9|Malignant|10767|103190694|Male|Total|2005|10.2|10.6|10.4
20+|14.0|14.4|14.2|Benign/Borderline|14303|104488268|Male|Total|2006|13.5|13.9|13.7
20+|10.5|10.9|10.7|Malignant|10804|104488268|Male|Total|2006|10.1|10.5|10.3
20+|14.3|14.8|14.5|Benign/Borderline|14939|105697783|Male|Total|2007|13.9|14.4|14.1
20+|10.5|10.9|10.7|Malignant|11037|105697783|Male|Total|2007|10.2|10.6|10.4
20+|15.1|15.6|15.3|Benign/Borderline|16017|106947980|Male|Total|2008|14.7|15.2|15.0
20+|10.6|11.0|10.8|Malignant|11326|106947980|Male|Total|2008|10.4|10.8|10.6
20+|15.9|16.4|16.1|Benign/Borderline|17093|108197539|Male|Total|2009|15.6|16.0|15.8
20+|10.4|10.8|10.6|Malignant|11380|108197539|Male|Total|2009|10.3|10.7|10.5
20+|15.7|16.2|16.0|Benign/Borderline|17281|109536975|Male|Total|2010|15.5|16.0|15.8
20+|10.2|10.5|10.3|Malignant|11337|109536975|Male|Total|2010|10.2|10.5|10.3
20+|16.0|16.2|16.1|Benign/Borderline|89844|556321335|Male|Total|2010-2014|16.0|16.3|16.1
20+|10.1|10.3|10.2|Malignant|57759|556321335|Male|Total|2010-2014|10.3|10.5|10.4
20+|15.7|16.2|16.0|Benign/Borderline|17466|109915911|Male|Total|2011|15.7|16.1|15.9
20+|10.2|10.6|10.4|Malignant|11483|109915911|Male|Total|2011|10.3|10.6|10.4
20+|16.0|16.5|16.3|Benign/Borderline|18321|112332773|Male|Total|2012|16.1|16.5|16.3
20+|10.0|10.3|10.2|Malignant|11597|112332773|Male|Total|2012|10.1|10.5|10.3
20+|16.1|16.5|16.3|Benign/Borderline|18689|113652712|Male|Total|2013|16.2|16.7|16.4
20+|9.9|10.3|10.1|Malignant|11757|113652712|Male|Total|2013|10.2|10.5|10.3
20+|15.6|16.0|15.8|Benign/Borderline|18437|114975678|Male|Total|2014|15.8|16.3|16.0
20+|9.9|10.3|10.1|Malignant|11947|114975678|Male|Total|2014|10.2|10.6|10.4
20+|2.2|2.3|2.3|Benign/Borderline|2297|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2646|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2607|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2691|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|19|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2644|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2806|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|.|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2806|109536975|Male|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|21|109536975|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|14833|556321335|Male|Tumors of Cranial and Spinal Nerves|2010-2014|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|101|556321335|Male|Tumors of Cranial and Spinal Nerves|2010-2014|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2855|109915911|Male|Tumors of Cranial and Spinal Nerves|2011|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|109915911|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3028|112332773|Male|Tumors of Cranial and Spinal Nerves|2012|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|25|112332773|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|3035|113652712|Male|Tumors of Cranial and Spinal Nerves|2013|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|113652712|Male|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3154|114975678|Male|Tumors of Cranial and Spinal Nerves|2014|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|.|114975678|Male|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|441|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8940|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|517|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.5|0.5
20+|8.9|9.3|9.1|Malignant|9061|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|549|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9165|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|512|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.8|9.2|9.0|Malignant|9361|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.7|9.0|8.9
20+|0.5|0.6|0.5|Benign/Borderline|577|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.9|9.2|9.1|Malignant|9614|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.8|9.2|9.0
20+|0.5|0.6|0.5|Benign/Borderline|581|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9678|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.8|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|632|109536975|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.6|9.0|8.8|Malignant|9692|109536975|Male|Tumors of Neuroepthelial Tissue|2010|8.7|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|3034|556321335|Male|Tumors of Neuroepthelial Tissue|2010-2014|0.5|0.6|0.5
20+|8.6|8.8|8.7|Malignant|49333|556321335|Male|Tumors of Neuroepthelial Tissue|2010-2014|8.8|8.9|8.9
20+|0.5|0.6|0.5|Benign/Borderline|579|109915911|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
20+|8.6|8.9|8.7|Malignant|9760|109915911|Male|Tumors of Neuroepthelial Tissue|2011|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|611|112332773|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.5
20+|8.5|8.8|8.6|Malignant|9921|112332773|Male|Tumors of Neuroepthelial Tissue|2012|8.7|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|583|113652712|Male|Tumors of Neuroepthelial Tissue|2013|0.5|0.6|0.5
20+|8.4|8.8|8.6|Malignant|10096|113652712|Male|Tumors of Neuroepthelial Tissue|2013|8.7|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|642|114975678|Male|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.6
20+|8.4|8.7|8.5|Malignant|10158|114975678|Male|Tumors of Neuroepthelial Tissue|2014|8.7|9.0|8.8
20+|3.4|3.7|3.5|Benign/Borderline|3529|101938779|Male|Tumors of Sellar Region|2004|3.3|3.6|3.5
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|3920|103190694|Male|Tumors of Sellar Region|2005|3.7|3.9|3.8
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|3.9|4.2|4.0|Benign/Borderline|4142|104488268|Male|Tumors of Sellar Region|2006|3.8|4.1|4.0
20+|0.0|0.0|0.0|Malignant|.|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4518|105697783|Male|Tumors of Sellar Region|2007|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|.|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.5|4.8|4.6|Benign/Borderline|4915|106947980|Male|Tumors of Sellar Region|2008|4.5|4.7|4.6
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.7|5.0|4.8|Benign/Borderline|5222|108197539|Male|Tumors of Sellar Region|2009|4.7|5.0|4.8
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.7|5.0|4.8|Benign/Borderline|5332|109536975|Male|Tumors of Sellar Region|2010|4.7|5.0|4.9
20+|~|~|~|Malignant|~|109536975|Male|Tumors of Sellar Region|2010|~|~|~
20+|4.9|5.0|5.0|Benign/Borderline|27976|556321335|Male|Tumors of Sellar Region|2010-2014|5.0|5.1|5.0
20+|0.0|0.0|0.0|Malignant|105|556321335|Male|Tumors of Sellar Region|2010-2014|0.0|0.0|0.0
20+|4.7|5.0|4.9|Benign/Borderline|5399|109915911|Male|Tumors of Sellar Region|2011|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|.|109915911|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.0|5.3|5.2|Benign/Borderline|5853|112332773|Male|Tumors of Sellar Region|2012|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|.|112332773|Male|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|4.9|5.2|5.0|Benign/Borderline|5836|113652712|Male|Tumors of Sellar Region|2013|5.0|5.3|5.1
20+|0.0|0.0|0.0|Malignant|25|113652712|Male|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|5654|114975678|Male|Tumors of Sellar Region|2014|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|.|114975678|Male|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.3|5.6|5.5|Benign/Borderline|5162|101938779|Male|Tumors of the Meninges|2004|4.9|5.2|5.1
20+|0.2|0.2|0.2|Malignant|198|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.9|6.2|6.0|Benign/Borderline|5749|103190694|Male|Tumors of the Meninges|2005|5.4|5.7|5.6
20+|0.2|0.2|0.2|Malignant|194|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.1|6.5|6.3|Benign/Borderline|6138|104488268|Male|Tumors of the Meninges|2006|5.7|6.0|5.9
20+|0.2|0.2|0.2|Malignant|183|104488268|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|6.2|6.5|6.4|Benign/Borderline|6327|105697783|Male|Tumors of the Meninges|2007|5.8|6.1|6.0
20+|0.2|0.2|0.2|Malignant|220|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.6|7.0|6.8|Benign/Borderline|6937|106947980|Male|Tumors of the Meninges|2008|6.3|6.6|6.5
20+|0.2|0.2|0.2|Malignant|196|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|7.1|7.4|7.2|Benign/Borderline|7427|108197539|Male|Tumors of the Meninges|2009|6.7|7.0|6.9
20+|0.2|0.2|0.2|Malignant|198|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|6.9|7.2|7.0|Benign/Borderline|7413|109536975|Male|Tumors of the Meninges|2010|6.6|6.9|6.8
20+|0.1|0.2|0.1|Malignant|154|109536975|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|6.9|7.1|7.0|Benign/Borderline|38339|556321335|Male|Tumors of the Meninges|2010-2014|6.8|7.0|6.9
20+|0.2|0.2|0.2|Malignant|913|556321335|Male|Tumors of the Meninges|2010-2014|0.2|0.2|0.2
20+|6.9|7.2|7.0|Benign/Borderline|7505|109915911|Male|Tumors of the Meninges|2011|6.7|7.0|6.8
20+|0.1|0.2|0.2|Malignant|185|109915911|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|6.7|7.1|6.9|Benign/Borderline|7625|112332773|Male|Tumors of the Meninges|2012|6.6|6.9|6.8
20+|0.1|0.2|0.2|Malignant|176|112332773|Male|Tumors of the Meninges|2012|0.1|0.2|0.2
20+|7.0|7.3|7.1|Benign/Borderline|8043|113652712|Male|Tumors of the Meninges|2013|6.9|7.2|7.1
20+|0.1|0.2|0.2|Malignant|195|113652712|Male|Tumors of the Meninges|2013|0.1|0.2|0.2
20+|6.7|7.0|6.9|Benign/Borderline|7931|114975678|Male|Tumors of the Meninges|2014|6.7|7.1|6.9
20+|0.1|0.2|0.2|Malignant|204|114975678|Male|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|0.6|0.7|0.7|Benign/Borderline|637|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|622|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|820|103190694|Male|Unclassified Tumors|2005|0.7|0.9|0.8
20+|0.6|0.7|0.7|Malignant|615|103190694|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|836|104488268|Male|Unclassified Tumors|2006|0.7|0.9|0.8
20+|0.6|0.7|0.6|Malignant|584|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|857|105697783|Male|Unclassified Tumors|2007|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|578|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.8|1.0|0.9|Benign/Borderline|911|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.9
20+|0.6|0.7|0.7|Malignant|632|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1023|108197539|Male|Unclassified Tumors|2009|0.9|1.0|0.9
20+|0.6|0.7|0.7|Malignant|653|108197539|Male|Unclassified Tumors|2009|0.6|0.7|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1072|109536975|Male|Unclassified Tumors|2010|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|615|109536975|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|5530|556321335|Male|Unclassified Tumors|2010-2014|1.0|1.0|1.0
20+|0.6|0.6|0.6|Malignant|3090|556321335|Male|Unclassified Tumors|2010-2014|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1103|109915911|Male|Unclassified Tumors|2011|0.9|1.1|1.0
20+|0.6|0.7|0.6|Malignant|621|109915911|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1175|112332773|Male|Unclassified Tumors|2012|1.0|1.1|1.0
20+|0.6|0.6|0.6|Malignant|632|112332773|Male|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1167|113652712|Male|Unclassified Tumors|2013|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|617|113652712|Male|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.8|1.0|0.9|Benign/Borderline|1029|114975678|Male|Unclassified Tumors|2014|0.8|1.0|0.9
20+|0.5|0.6|0.6|Malignant|649|114975678|Male|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.1|0.1|0.1|Benign/Borderline|96|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|112|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|135|104488268|Male|Unique astrocytoma variants|2006|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|121|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|146|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|155|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|179|109536975|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109536975|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|845|556321335|Male|Unique astrocytoma variants|2010-2014|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|158|556321335|Male|Unique astrocytoma variants|2010-2014|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|177|109915911|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|109915911|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|170|112332773|Male|Unique astrocytoma variants|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|112332773|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|159|113652712|Male|Unique astrocytoma variants|2013|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|38|113652712|Male|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|164|114975678|Male|Unique astrocytoma variants|2014|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|39|114975678|Male|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|40|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|226161412|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|226161412|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|150|1147371644|Male and Female|All other|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|204|1147371644|Male and Female|All other|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|226884908|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|226884908|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|231602469|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|33|231602469|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|234150358|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|234150358|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|236751262|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|45|236751262|Male and Female|All other|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1236|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1209|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1206|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1198|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1208|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1211|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|1262|226161412|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Anaplastic astrocytoma|2010-2014|~|~|~
20+|0.6|0.6|0.6|Malignant|6607|1147371644|Male and Female|Anaplastic astrocytoma|2010-2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1259|226884908|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1326|231602469|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1413|234150358|Male and Female|Anaplastic astrocytoma|2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|1386|236751262|Male and Female|Anaplastic astrocytoma|2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|390|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|373|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|351|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|335|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|357|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|326|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|319|226161412|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Anaplastic oligodendroglioma|2010-2014|~|~|~
20+|0.1|0.2|0.1|Malignant|1691|1147371644|Male and Female|Anaplastic oligodendroglioma|2010-2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|324|226884908|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|348|231602469|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.2|Malignant|360|234150358|Male and Female|Anaplastic oligodendroglioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|348|236751262|Male and Female|Anaplastic oligodendroglioma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1202|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1186|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1180|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1155|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1110|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1051|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1082|226161412|Male and Female|Astrocytoma, NOS|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Astrocytoma, NOS|2010-2014|~|~|~
20+|0.4|0.5|0.4|Malignant|5151|1147371644|Male and Female|Astrocytoma, NOS|2010-2014|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|1021|226884908|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|1024|231602469|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.4|0.4|Malignant|985|234150358|Male and Female|Astrocytoma, NOS|2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|1055|236751262|Male and Female|Astrocytoma, NOS|2014|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|62|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|75|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|68|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|87|218481776|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|74|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|84|226161412|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226161412|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|395|1147371644|Male and Female|Choroid plexus|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|1147371644|Male and Female|Choroid plexus|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|82|226884908|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226884908|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|69|231602469|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|231602469|Male and Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|76|234150358|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|234150358|Male and Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|84|236751262|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|236751262|Male and Female|Choroid plexus|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|382|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|413|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|388|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|412|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|418|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|426|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|434|226161412|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226161412|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2122|1147371644|Male and Female|Craniopharyngioma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1147371644|Male and Female|Craniopharyngioma|2010-2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|406|226884908|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226884908|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|432|231602469|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231602469|Male and Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|458|234150358|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|234150358|Male and Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|403|236751262|Male and Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236751262|Male and Female|Craniopharyngioma|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|256|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|293|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|317|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|339|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|368|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|349|226161412|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Diffuse astrocytoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|1097|1147371644|Male and Female|Diffuse astrocytoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|245|226884908|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|207|231602469|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|173|234150358|Male and Female|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|129|236751262|Male and Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|167|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|189|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|170|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|215|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|212|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|236|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|197|226161412|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Embryonal/primitive/medulloblastoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|917|1147371644|Male and Female|Embryonal/primitive/medulloblastoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|187|226884908|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|173|231602469|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|184|234150358|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|179|236751262|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|246|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|268|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|306|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|247|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|258|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|273|226161412|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226161412|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1380|1147371644|Male and Female|Ependymoma variants|2010-2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|1147371644|Male and Female|Ependymoma variants|2010-2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|263|226884908|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226884908|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|289|231602469|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|231602469|Male and Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|272|234150358|Male and Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|234150358|Male and Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|285|236751262|Male and Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|236751262|Male and Female|Ependymoma variants|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|589|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|599|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|580|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|581|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|633|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|675|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|618|226161412|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|82|1147371644|Male and Female|Ependymoma/anaplastic ependymoma|2010-2014|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|2921|1147371644|Male and Female|Ependymoma/anaplastic ependymoma|2010-2014|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|226884908|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|587|226884908|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|623|231602469|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|566|234150358|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|29|236751262|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|545|236751262|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|67|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|69|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|74|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|57|226161412|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226161412|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|279|1147371644|Male and Female|Germ Cell Tumors|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|296|1147371644|Male and Female|Germ Cell Tumors|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|57|226884908|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|66|226884908|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|231602469|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|231602469|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|234150358|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|234150358|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|57|236751262|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|66|236751262|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9548|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.5|4.4|Malignant|9682|213511339|Male and Female|Glioblastoma|2005|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9798|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10175|218481776|Male and Female|Glioblastoma|2007|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10398|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.3|4.5|4.4|Malignant|10467|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Glioblastoma|2010|~|~|~
20+|4.3|4.5|4.4|Malignant|10708|226161412|Male and Female|Glioblastoma|2010|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Glioblastoma|2010-2014|~|~|~
20+|4.4|4.5|4.4|Malignant|55466|1147371644|Male and Female|Glioblastoma|2010-2014|4.8|4.9|4.8
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10781|226884908|Male and Female|Glioblastoma|2011|4.7|4.8|4.8
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.6|4.5|Malignant|11353|231602469|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Glioblastoma|2013|~|~|~
20+|4.4|4.5|4.5|Malignant|11510|234150358|Male and Female|Glioblastoma|2013|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Glioblastoma|2014|~|~|~
20+|4.3|4.4|4.4|Malignant|11462|236751262|Male and Female|Glioblastoma|2014|4.8|4.9|4.8
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|845|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|829|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|17|216055494|Male and Female|Glioma malignant, NOS|2006|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|834|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|869|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|909|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|962|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|226161412|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|811|226161412|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|135|1147371644|Male and Female|Glioma malignant, NOS|2010-2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4396|1147371644|Male and Female|Glioma malignant, NOS|2010-2014|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|25|226884908|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|917|226884908|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|27|231602469|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|907|231602469|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|234150358|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|893|234150358|Male and Female|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|35|236751262|Male and Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|895|236751262|Male and Female|Glioma malignant, NOS|2014|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|450|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|509|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|497|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|468|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|526|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|502|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|523|226161412|Male and Female|Hemangioblastoma|2010|0.2|0.3|0.2
20+|~|~|~|Malignant|~|226161412|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2500|1147371644|Male and Female|Hemangioblastoma|2010-2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1147371644|Male and Female|Hemangioblastoma|2010-2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|501|226884908|Male and Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226884908|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|522|231602469|Male and Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231602469|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|498|234150358|Male and Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|234150358|Male and Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|466|236751262|Male and Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236751262|Male and Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|365|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|471|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|530|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|622|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|762|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.3
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|913|223491138|Male and Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1068|226161412|Male and Female|Hemangioma|2010|0.4|0.5|0.5
20+|~|~|~|Malignant|~|226161412|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|5586|1147371644|Male and Female|Hemangioma|2010-2014|0.5|0.5|0.5
20+|0.0|0.0|0.0|Malignant|18|1147371644|Male and Female|Hemangioma|2010-2014|0.0|0.0|0.0
20+|0.5|0.5|0.5|Benign/Borderline|1176|226884908|Male and Female|Hemangioma|2011|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226884908|Male and Female|Hemangioma|2011|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1167|231602469|Male and Female|Hemangioma|2012|0.5|0.5|0.5
20+|~|~|~|Malignant|~|231602469|Male and Female|Hemangioma|2012|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1169|234150358|Male and Female|Hemangioma|2013|0.5|0.5|0.5
20+|~|~|~|Malignant|~|234150358|Male and Female|Hemangioma|2013|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|1018|236751262|Male and Female|Hemangioma|2014|0.4|0.5|0.4
20+|~|~|~|Malignant|~|236751262|Male and Female|Hemangioma|2014|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|52|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|53|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226161412|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Local Extensions from Regional Tumors|2010-2014|~|~|~
20+|0.0|0.0|0.0|Malignant|236|1147371644|Male and Female|Local Extensions from Regional Tumors|2010-2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|42|226884908|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|49|231602469|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|43|234150358|Male and Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|51|236751262|Male and Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1341|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1437|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1431|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1373|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1471|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.6|0.6|Malignant|1420|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1506|226161412|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|~|~|~
20+|0.6|0.6|0.6|Malignant|7508|1147371644|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010-2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1512|226884908|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1453|231602469|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1467|234150358|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.6|Malignant|1613|236751262|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|0.6|0.7|0.7
20+|8.7|9.0|8.8|Benign/Borderline|18764|211050944|Male and Female|Meningioma|2004|8.8|9.0|8.9
20+|0.2|0.2|0.2|Malignant|440|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.7|10.0|9.9|Benign/Borderline|21338|213511339|Male and Female|Meningioma|2005|9.9|10.1|10.0
20+|0.2|0.2|0.2|Malignant|435|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.2|10.5|10.3|Benign/Borderline|22727|216055494|Male and Female|Meningioma|2006|10.4|10.7|10.5
20+|0.2|0.2|0.2|Malignant|404|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.5|10.8|10.6|Benign/Borderline|23756|218481776|Male and Female|Meningioma|2007|10.7|11.0|10.9
20+|0.2|0.2|0.2|Malignant|443|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|11.0|11.3|11.2|Benign/Borderline|25457|220975702|Male and Female|Meningioma|2008|11.4|11.7|11.5
20+|0.1|0.2|0.2|Malignant|363|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|11.7|12.0|11.8|Benign/Borderline|27452|223491138|Male and Female|Meningioma|2009|12.1|12.4|12.3
20+|0.1|0.2|0.1|Malignant|352|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|11.2|11.5|11.4|Benign/Borderline|26919|226161412|Male and Female|Meningioma|2010|11.8|12.0|11.9
20+|0.1|0.2|0.1|Malignant|324|226161412|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|11.3|11.4|11.4|Benign/Borderline|138228|1147371644|Male and Female|Meningioma|2010-2014|12.0|12.1|12.0
20+|0.1|0.1|0.1|Malignant|1726|1147371644|Male and Female|Meningioma|2010-2014|0.1|0.2|0.2
20+|11.3|11.6|11.4|Benign/Borderline|27272|226884908|Male and Female|Meningioma|2011|11.9|12.2|12.0
20+|0.1|0.2|0.1|Malignant|323|226884908|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|11.2|11.5|11.4|Benign/Borderline|27869|231602469|Male and Female|Meningioma|2012|11.9|12.2|12.0
20+|0.1|0.2|0.1|Malignant|346|231602469|Male and Female|Meningioma|2012|0.1|0.2|0.1
20+|11.2|11.5|11.4|Benign/Borderline|28421|234150358|Male and Female|Meningioma|2013|12.0|12.3|12.1
20+|0.1|0.2|0.1|Malignant|371|234150358|Male and Female|Meningioma|2013|0.1|0.2|0.2
20+|11.0|11.3|11.1|Benign/Borderline|28378|236751262|Male and Female|Meningioma|2014|11.8|12.1|12.0
20+|0.1|0.2|0.1|Malignant|363|236751262|Male and Female|Meningioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|487|211050944|Male and Female|Mixed glioma|2004|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|567|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|637|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|587|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|596|220975702|Male and Female|Mixed glioma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|675|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|609|226161412|Male and Female|Mixed glioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Mixed glioma|2010-2014|~|~|~
20+|0.2|0.3|0.3|Malignant|2860|1147371644|Male and Female|Mixed glioma|2010-2014|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|626|226884908|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|564|231602469|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Mixed glioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|619|234150358|Male and Female|Mixed glioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Mixed glioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|459|236751262|Male and Female|Mixed glioma|2014|0.2|0.2|0.2
20+|0.5|0.6|0.6|Benign/Borderline|1184|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1317|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1491|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1324|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1402|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1295|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1424|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1219|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1421|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1373|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1514|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1428|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1457|226161412|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1251|226161412|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|7199|1147371644|Male and Female|Neoplasm, unspecified|2010-2014|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|6295|1147371644|Male and Female|Neoplasm, unspecified|2010-2014|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1429|226884908|Male and Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1241|226884908|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|1517|231602469|Male and Female|Neoplasm, unspecified|2012|0.6|0.7|0.7
20+|0.5|0.5|0.5|Malignant|1283|231602469|Male and Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1444|234150358|Male and Female|Neoplasm, unspecified|2013|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1266|234150358|Male and Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|1383|236751262|Male and Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.5|0.6|0.5|Malignant|1341|236751262|Male and Female|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|2.2|2.3|2.2|Benign/Borderline|4817|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5430|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5507|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5585|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|58|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5637|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|5956|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|35|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5731|226161412|Male and Female|Nerve sheath, benign and malignant|2010|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|43|226161412|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|30866|1147371644|Male and Female|Nerve sheath, benign and malignant|2010-2014|2.7|2.7|2.7
20+|0.0|0.0|0.0|Malignant|206|1147371644|Male and Female|Nerve sheath, benign and malignant|2010-2014|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5998|226884908|Male and Female|Nerve sheath, benign and malignant|2011|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|36|226884908|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6315|231602469|Male and Female|Nerve sheath, benign and malignant|2012|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|50|231602469|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6408|234150358|Male and Female|Nerve sheath, benign and malignant|2013|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|43|234150358|Male and Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6495|236751262|Male and Female|Nerve sheath, benign and malignant|2014|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|35|236751262|Male and Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226161412|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|1147371644|Male and Female|Neuroepithelial|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|256|1147371644|Male and Female|Neuroepithelial|2010-2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|49|226884908|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|54|231602469|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|48|234150358|Male and Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|54|236751262|Male and Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|312|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|369|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|54|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|383|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|384|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|45|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|418|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|436|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|42|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|477|226161412|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|35|226161412|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2110|1147371644|Male and Female|Neuronal/glial, neuronal|2010-2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|175|1147371644|Male and Female|Neuronal/glial, neuronal|2010-2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|416|226884908|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|38|226884908|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|407|231602469|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|231602469|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|383|234150358|Male and Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|234150358|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|435|236751262|Male and Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|32|236751262|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|823|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.4|Malignant|788|213511339|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|835|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.4|Malignant|802|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|757|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|821|223491138|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|788|226161412|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Oligodendroglioma|2010-2014|~|~|~
20+|0.3|0.3|0.3|Malignant|3549|1147371644|Male and Female|Oligodendroglioma|2010-2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|742|226884908|Male and Female|Oligodendroglioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|653|231602469|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|691|234150358|Male and Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Oligodendroglioma|2014|~|~|~
20+|0.3|0.3|0.3|Malignant|692|236751262|Male and Female|Oligodendroglioma|2014|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|147|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|54|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|152|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|61|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|154|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|165|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|76|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|200|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|97|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|196|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|168|226161412|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|226161412|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|852|1147371644|Male and Female|Other mesenchymal|2010-2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|364|1147371644|Male and Female|Other mesenchymal|2010-2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|154|226884908|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|72|226884908|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|200|231602469|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|231602469|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|168|234150358|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|83|234150358|Male and Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|162|236751262|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|77|236751262|Male and Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|274|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|304|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|307|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|303|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|289|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|271|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226161412|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|328|226161412|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1147371644|Male and Female|Pilocytic astrocytoma|2010-2014|~|~|~
20+|0.1|0.1|0.1|Malignant|1498|1147371644|Male and Female|Pilocytic astrocytoma|2010-2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226884908|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|329|226884908|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231602469|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|266|231602469|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|234150358|Male and Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|297|234150358|Male and Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236751262|Male and Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|285|236751262|Male and Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|44|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|54|226161412|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226161412|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|290|1147371644|Male and Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|228|1147371644|Male and Female|Pineal parenchymal|2010-2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|226884908|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226884908|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|59|231602469|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|231602469|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|234150358|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|70|234150358|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|57|236751262|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|236751262|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|3.4|3.5|3.5|Benign/Borderline|7326|211050944|Male and Female|Pituitary|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|8336|213511339|Male and Female|Pituitary|2005|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|9083|216055494|Male and Female|Pituitary|2006|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|30|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9594|218481776|Male and Female|Pituitary|2007|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|10347|220975702|Male and Female|Pituitary|2008|4.6|4.8|4.7
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|11283|223491138|Male and Female|Pituitary|2009|5.0|5.1|5.0
20+|0.0|0.0|0.0|Malignant|22|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|4.9|5.0|5.0|Benign/Borderline|11298|226161412|Male and Female|Pituitary|2010|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|28|226161412|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|5.0|5.1|5.0|Benign/Borderline|58464|1147371644|Male and Female|Pituitary|2010-2014|5.1|5.1|5.1
20+|0.0|0.0|0.0|Malignant|171|1147371644|Male and Female|Pituitary|2010-2014|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|11486|226884908|Male and Female|Pituitary|2011|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|36|226884908|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|5.2|5.3|5.2|Benign/Borderline|12223|231602469|Male and Female|Pituitary|2012|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|31|231602469|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|5.0|5.1|5.0|Benign/Borderline|11995|234150358|Male and Female|Pituitary|2013|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|41|234150358|Male and Female|Pituitary|2013|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|11664|236751262|Male and Female|Pituitary|2014|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|35|236751262|Male and Female|Pituitary|2014|0.0|0.0|0.0
20+|16.0|16.3|16.1|Benign/Borderline|34299|211050944|Male and Female|Total|2004|16.1|16.4|16.3
20+|9.0|9.2|9.1|Malignant|19336|211050944|Male and Female|Total|2004|9.0|9.3|9.2
20+|18.0|18.4|18.2|Benign/Borderline|39173|213511339|Male and Female|Total|2005|18.2|18.5|18.3
20+|9.0|9.2|9.1|Malignant|19657|213511339|Male and Female|Total|2005|9.1|9.3|9.2
20+|18.7|19.1|18.9|Benign/Borderline|41393|216055494|Male and Female|Total|2006|19.0|19.3|19.2
20+|8.9|9.1|9.0|Malignant|19768|216055494|Male and Female|Total|2006|9.0|9.3|9.1
20+|19.2|19.5|19.4|Benign/Borderline|43093|218481776|Male and Female|Total|2007|19.5|19.9|19.7
20+|8.9|9.1|9.0|Malignant|20079|218481776|Male and Female|Total|2007|9.1|9.3|9.2
20+|20.1|20.5|20.3|Benign/Borderline|45907|220975702|Male and Female|Total|2008|20.6|21.0|20.8
20+|8.9|9.2|9.0|Malignant|20521|220975702|Male and Female|Total|2008|9.2|9.4|9.3
20+|21.3|21.7|21.5|Benign/Borderline|49416|223491138|Male and Female|Total|2009|21.9|22.3|22.1
20+|8.8|9.1|8.9|Malignant|20718|223491138|Male and Female|Total|2009|9.1|9.4|9.3
20+|20.7|21.1|20.9|Benign/Borderline|48838|226161412|Male and Female|Total|2010|21.4|21.8|21.6
20+|8.6|8.9|8.7|Malignant|20614|226161412|Male and Female|Total|2010|9.0|9.2|9.1
20+|21.0|21.1|21.0|Benign/Borderline|251857|1147371644|Male and Female|Total|2010-2014|21.9|22.0|22.0
20+|8.5|8.6|8.6|Malignant|104087|1147371644|Male and Female|Total|2010-2014|9.0|9.1|9.1
20+|20.9|21.3|21.1|Benign/Borderline|49620|226884908|Male and Female|Total|2011|21.7|22.1|21.9
20+|8.5|8.8|8.6|Malignant|20568|226884908|Male and Female|Total|2011|8.9|9.2|9.1
20+|21.1|21.5|21.3|Benign/Borderline|51447|231602469|Male and Female|Total|2012|22.0|22.4|22.2
20+|8.5|8.7|8.6|Malignant|20999|231602469|Male and Female|Total|2012|8.9|9.2|9.1
20+|20.9|21.2|21.1|Benign/Borderline|51716|234150358|Male and Female|Total|2013|21.9|22.3|22.1
20+|8.4|8.7|8.5|Malignant|21301|234150358|Male and Female|Total|2013|9.0|9.2|9.1
20+|20.4|20.7|20.5|Benign/Borderline|51231|236751262|Male and Female|Total|2014|21.5|21.8|21.6
20+|8.3|8.5|8.4|Malignant|21252|236751262|Male and Female|Total|2014|8.9|9.1|9.0
20+|2.2|2.3|2.2|Benign/Borderline|4817|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5433|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5509|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5587|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|58|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5641|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|5962|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|35|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5735|226161412|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|43|226161412|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|30889|1147371644|Male and Female|Tumors of Cranial and Spinal Nerves|2010-2014|2.7|2.7|2.7
20+|0.0|0.0|0.0|Malignant|206|1147371644|Male and Female|Tumors of Cranial and Spinal Nerves|2010-2014|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6003|226884908|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|36|226884908|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6317|231602469|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|50|231602469|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6413|234150358|Male and Female|Tumors of Cranial and Spinal Nerves|2013|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|43|234150358|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6502|236751262|Male and Female|Tumors of Cranial and Spinal Nerves|2014|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|35|236751262|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|818|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.6|7.5|Malignant|15977|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.5|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|956|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.4
20+|7.4|7.6|7.5|Malignant|16183|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1027|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
20+|7.3|7.6|7.5|Malignant|16375|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|988|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16732|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.5|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1059|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17010|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1088|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17272|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.6|7.8|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1172|226161412|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17256|226161412|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|5708|1147371644|Male and Female|Tumors of Neuroepthelial Tissue|2010-2014|0.5|0.5|0.5
20+|7.1|7.2|7.2|Malignant|87174|1147371644|Male and Female|Tumors of Neuroepthelial Tissue|2010-2014|7.5|7.6|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1129|226884908|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17216|226884908|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1136|231602469|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17653|231602469|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1094|234150358|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17917|234150358|Male and Female|Tumors of Neuroepthelial Tissue|2013|7.5|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1194|236751262|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.5|0.5
20+|6.9|7.1|7.0|Malignant|17643|236751262|Male and Female|Tumors of Neuroepthelial Tissue|2014|7.3|7.6|7.5
20+|3.6|3.7|3.6|Benign/Borderline|7708|211050944|Male and Female|Tumors of Sellar Region|2004|3.6|3.7|3.7
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|8749|213511339|Male and Female|Tumors of Sellar Region|2005|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9471|216055494|Male and Female|Tumors of Sellar Region|2006|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|32|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.5|4.6|4.6|Benign/Borderline|10006|218481776|Male and Female|Tumors of Sellar Region|2007|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.8|4.9|4.9|Benign/Borderline|10765|220975702|Male and Female|Tumors of Sellar Region|2008|4.8|5.0|4.9
20+|~|~|~|Malignant|~|220975702|Male and Female|Tumors of Sellar Region|2008|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|11709|223491138|Male and Female|Tumors of Sellar Region|2009|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|23|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.0|5.2|5.1|Benign/Borderline|11732|226161412|Male and Female|Tumors of Sellar Region|2010|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|28|226161412|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.2|5.3|5.2|Benign/Borderline|60586|1147371644|Male and Female|Tumors of Sellar Region|2010-2014|5.2|5.3|5.3
20+|0.0|0.0|0.0|Malignant|178|1147371644|Male and Female|Tumors of Sellar Region|2010-2014|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|11892|226884908|Male and Female|Tumors of Sellar Region|2011|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|38|226884908|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12655|231602469|Male and Female|Tumors of Sellar Region|2012|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|31|231602469|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|12453|234150358|Male and Female|Tumors of Sellar Region|2013|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|42|234150358|Male and Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|12067|236751262|Male and Female|Tumors of Sellar Region|2014|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|39|236751262|Male and Female|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|9.0|9.2|9.1|Benign/Borderline|19361|211050944|Male and Female|Tumors of the Meninges|2004|9.0|9.3|9.2
20+|0.2|0.3|0.2|Malignant|495|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|10.0|10.3|10.2|Benign/Borderline|21999|213511339|Male and Female|Tumors of the Meninges|2005|10.2|10.4|10.3
20+|0.2|0.3|0.2|Malignant|499|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.5|10.8|10.6|Benign/Borderline|23378|216055494|Male and Female|Tumors of the Meninges|2006|10.7|11.0|10.8
20+|0.2|0.2|0.2|Malignant|467|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.8|11.0|10.9|Benign/Borderline|24389|218481776|Male and Female|Tumors of the Meninges|2007|11.0|11.3|11.2
20+|0.2|0.3|0.2|Malignant|525|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.3|11.6|11.5|Benign/Borderline|26183|220975702|Male and Female|Tumors of the Meninges|2008|11.7|12.0|11.8
20+|0.2|0.2|0.2|Malignant|464|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|12.0|12.3|12.1|Benign/Borderline|28150|223491138|Male and Female|Tumors of the Meninges|2009|12.4|12.7|12.6
20+|0.2|0.2|0.2|Malignant|426|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|11.5|11.8|11.7|Benign/Borderline|27610|226161412|Male and Female|Tumors of the Meninges|2010|12.1|12.4|12.2
20+|0.1|0.2|0.2|Malignant|393|226161412|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|11.6|11.7|11.6|Benign/Borderline|141580|1147371644|Male and Female|Tumors of the Meninges|2010-2014|12.3|12.4|12.3
20+|0.2|0.2|0.2|Malignant|2104|1147371644|Male and Female|Tumors of the Meninges|2010-2014|0.2|0.2|0.2
20+|11.6|11.9|11.7|Benign/Borderline|27927|226884908|Male and Female|Tumors of the Meninges|2011|12.2|12.5|12.3
20+|0.2|0.2|0.2|Malignant|396|226884908|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|11.5|11.8|11.7|Benign/Borderline|28591|231602469|Male and Female|Tumors of the Meninges|2012|12.2|12.5|12.3
20+|0.2|0.2|0.2|Malignant|412|231602469|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|11.5|11.8|11.7|Benign/Borderline|29087|234150358|Male and Female|Tumors of the Meninges|2013|12.3|12.6|12.4
20+|0.2|0.2|0.2|Malignant|458|234150358|Male and Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|11.3|11.5|11.4|Benign/Borderline|29006|236751262|Male and Female|Tumors of the Meninges|2014|12.1|12.4|12.3
20+|0.2|0.2|0.2|Malignant|447|236751262|Male and Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1554|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1330|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1967|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1337|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.9|0.9|0.9|Benign/Borderline|1942|216055494|Male and Female|Unclassified Tumors|2006|0.9|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1311|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2052|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|1229|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|2193|220975702|Male and Female|Unclassified Tumors|2008|1.0|1.0|1.0
20+|0.6|0.6|0.6|Malignant|1398|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2430|223491138|Male and Female|Unclassified Tumors|2009|1.0|1.1|1.1
20+|0.6|0.7|0.6|Malignant|1445|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2530|226161412|Male and Female|Unclassified Tumors|2010|1.1|1.2|1.1
20+|0.5|0.6|0.5|Malignant|1272|226161412|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.1|1.1|Benign/Borderline|12807|1147371644|Male and Female|Unclassified Tumors|2010-2014|1.1|1.1|1.1
20+|0.5|0.5|0.5|Malignant|6385|1147371644|Male and Female|Unclassified Tumors|2010-2014|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2611|226884908|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1262|226884908|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2685|231602469|Male and Female|Unclassified Tumors|2012|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1300|231602469|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2620|234150358|Male and Female|Unclassified Tumors|2013|1.1|1.2|1.1
20+|0.5|0.5|0.5|Malignant|1280|234150358|Male and Female|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.9|1.0|1.0|Benign/Borderline|2404|236751262|Male and Female|Unclassified Tumors|2014|1.0|1.1|1.0
20+|0.5|0.6|0.5|Malignant|1358|236751262|Male and Female|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.1|0.1|0.1|Benign/Borderline|149|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|183|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|183|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|202|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|56|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|230|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|247|226161412|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|46|226161412|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1271|1147371644|Male and Female|Unique astrocytoma variants|2010-2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|302|1147371644|Male and Female|Unique astrocytoma variants|2010-2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|257|226884908|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|58|226884908|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|268|231602469|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|231602469|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|250|234150358|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|68|234150358|Male and Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|254|236751262|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|75|236751262|Male and Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
